<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Physiol.</journal-id>
<journal-title>Frontiers in Physiology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Physiol.</abbrev-journal-title>
<issn pub-type="epub">1664-042X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fphys.2016.00360</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Physiology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Molecular Properties of Globin Channels and Pores: Role of Cholesterol in Ligand Binding and Movement</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name><surname>Morrill</surname> <given-names>Gene A.</given-names></name>
<xref ref-type="author-notes" rid="fn001"><sup>&#x0002A;</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/352943/overview"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Kostellow</surname> <given-names>Adele B.</given-names></name>
</contrib>
</contrib-group>
<aff><institution>Department of Physiology and Biophysics, Albert Einstein College of Medicine</institution> <country>Bronx, NY, USA</country></aff>
<author-notes>
<fn fn-type="edited-by"><p>Edited by: Francisco Monroy, Complutense University of Madrid, Spain</p></fn>
<fn fn-type="edited-by"><p>Reviewed by: Irena Levitan, University of Illinois at Chicago, USA; Francisco J. Barrantes, Pontifical Catholic University of Argentina and the National Scientific and Technical Research Council, Argentina</p></fn>
<fn fn-type="corresp" id="fn001"><p>&#x0002A;Correspondence: Gene A. Morrill <email>gene.morrill&#x00040;einstein.yu.edu</email></p></fn>
<fn fn-type="other" id="fn002"><p>This article was submitted to Biophysics, a section of the journal Frontiers in Physiology</p></fn>
</author-notes>
<pub-date pub-type="epub">
<day>05</day>
<month>09</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="collection">
<year>2016</year>
</pub-date>
<volume>7</volume>
<elocation-id>360</elocation-id>
<history>
<date date-type="received">
<day>17</day>
<month>06</month>
<year>2016</year>
</date>
<date date-type="accepted">
<day>08</day>
<month>08</month>
<year>2016</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x000A9; 2016 Morrill and Kostellow.</copyright-statement>
<copyright-year>2016</copyright-year>
<copyright-holder>Morrill and Kostellow</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/"><p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p></license>
</permissions>
<abstract>
<p>Globins contain one or more cavities that control or affect such functions as ligand movement and ligand binding. Here we report that the extended globin family [cytoglobin (Cygb); neuroglobin (Ngb); myoglobin (Mb); hemoglobin (Hb) subunits Hba(&#x003B1;); and Hbb(&#x003B2;)] contain either a transmembrane (TM) helix or pore-lining region as well as internal cavities. Protein motif/domain analyses indicate that Ngb and Hbb each contain 5 cholesterol- binding (CRAC/CARC) domains and 1 caveolin binding motif, whereas the Cygb dimer has 6 cholesterol-binding domains but lacks caveolin-binding motifs. Mb and Hba each exhibit 2 cholesterol-binding domains and also lack caveolin-binding motifs. The Hb &#x003B1;&#x003B2;-tetramer contains 14 cholesterol-binding domains. Computer algorithms indicate that Cygb and Ngb cavities display multiple partitions and C-terminal pore-lining regions, whereas Mb has three major cavities plus a C-terminal pore-lining region. The Hb tetramer exhibits a large internal cavity but the subunits differ in that they contain a C-terminal TM helix (Hba) and pore-lining region (Hbb). The cavities include 43 of 190 Cygb residues, 38 of 151 of Ngb residues, 55 of 154 Mb residues, and 137 of 688 residues in the Hb tetramer. Each cavity complex includes 6 to 8 residues of the TM helix or pore-lining region and CRAC/CARC domains exist within all cavities. Erythrocyte Hb &#x003B1;&#x003B2;-tetramers are largely cytosolic but also bind to a membrane anion exchange protein, &#x0201C;band 3,&#x0201D; which contains a large internal cavity and 12 TM helices (5 being pore-lining regions). The Hba TM helix may be the erythrocyte membrane &#x0201C;band 3&#x0201D; attachment site. &#x0201C;Band 3&#x0201D; contributes 4 caveolin binding motifs and 10 CRAC/CARC domains. Cholesterol binding may create lipid-disordered phases that alter globin cavities and facilitate ligand movement, permitting ion channel formation and conformational changes that orchestrate anion and ligand (O<sub>2</sub>, CO<sub>2</sub>, NO) movement within the large internal cavities and channels of the globins.</p>
</abstract>
<kwd-group>
<kwd>Globins</kwd>
<kwd>band-3 protein</kwd>
<kwd>cholesterol</kwd>
<kwd>protein cavities</kwd>
<kwd>channels</kwd>
<kwd>ligands</kwd>
</kwd-group>
<contract-sponsor id="cn001">National Institutes of Health<named-content content-type="fundref-id">10.13039/100000002</named-content></contract-sponsor>
<counts>
<fig-count count="7"/>
<table-count count="5"/>
<equation-count count="0"/>
<ref-count count="70"/>
<page-count count="18"/>
<word-count count="9989"/>
</counts>
</article-meta>
</front>
<body>
<sec id="s1">
<title>Background</title>
<p>Globins are small respiratory proteins that reversibly bind O<sub>2</sub> by means of an iron-containing porphyrinring. Globin-like proteins have been identified in bacteria, plants, fungi, and animals (Hardison, <xref ref-type="bibr" rid="B28">1996</xref>, <xref ref-type="bibr" rid="B29">1998</xref>) and contain internal cavities and packing anomalies that appear to reduce thermodynamic stability but may actually provide interior pathways for the diffusion of ligands (Brunori and Gibson, <xref ref-type="bibr" rid="B8">2001</xref>; Teeter, <xref ref-type="bibr" rid="B64">2004</xref>; Brunori et al., <xref ref-type="bibr" rid="B9">2005</xref>; Olson et al., <xref ref-type="bibr" rid="B49">2007</xref>). The pathways and mechanism of movement of ligands within protein cavities and tunnels have been studied by spectroscopy, by crystallography, and by stimulation as well as by mutagenesis mapping experiments (e.g., Tomita et al., <xref ref-type="bibr" rid="B66">2009</xref>; Salter et al., <xref ref-type="bibr" rid="B57">2012</xref>) and have been characterized using molecular dynamics simulations (e.g., Paramo et al., <xref ref-type="bibr" rid="B51">2014</xref>). Studies of myoglobin suggest that thermally or photo-dissociated ligands first migrate into open spaces within the globin interior and then diffuse back to the distal pocket, where they either rebind to the iron or escape from the protein through a gate regulated by motions of His(E7)64 (reviewed in Tomita et al., <xref ref-type="bibr" rid="B66">2009</xref>). Salter et al. (<xref ref-type="bibr" rid="B57">2012</xref>), applying a mutagenesis mapping strategy to the neuronal mini-hemoglobin from <italic>Cerebratulus lacteus</italic>, identified multiple internal pathways for O2 entry into and exit from the globin.</p>
<p>Studies on structural and functional variation within the globin superfamily adds evidence to the hypothesis that hemoglobin and myoglobin are two specialized heme proteins within a broad evolutionary family that evolved enabling larger and more efficient animals (Richter et al., <xref ref-type="bibr" rid="B54">2009</xref>). Cytoglobin (Cygb) is a more recently identified intracellular globin that i s expressed ubiquitously in low levels in human tissues and exists as a dimer (reviewed in Pesce et al., <xref ref-type="bibr" rid="B53">2002</xref>). Neuroglobin (Ngb) is monomeric and is expressed in specific areas of the brain, notably the frontal lobe, subthalamic nucleus, and thalamus (Mammen et al., <xref ref-type="bibr" rid="B41">2002</xref>; Pesce et al., <xref ref-type="bibr" rid="B53">2002</xref>), although at &#x003BC;M concentrations. Myoglobin (Mb) is a monomeric protein found in muscle tissue of vertebrates in general and it is related to the &#x003B1;-subunit of hemoglobin (Hb; Teeter, <xref ref-type="bibr" rid="B64">2004</xref>). Hb is a tetramer (ABAB) containing both &#x003B1; and &#x003B2; subunits. In mammals it makes up about 96% of the red blood cells&#x00027; dry content (by weight; Weed et al., <xref ref-type="bibr" rid="B70">1963</xref>). Neurons also express hemoglobin &#x003B1; (Hba) and &#x003B2; (Hbb) chains in both rat and human brains (Richter et al., <xref ref-type="bibr" rid="B54">2009</xref>). Hba and Hba-like molecules are also found in many invertebrates, fungi, and plants (e.g., Weber and Vinogradov, <xref ref-type="bibr" rid="B69">2001</xref>). <italic>In silico</italic> analysis of the genome of <italic>C. elegans</italic> identified 33 putative globin genes and, as noted by the authors, it is a &#x0201C;mystery why such a tiny animal needs so many globins&#x0201D; (Hoogewijs et al., <xref ref-type="bibr" rid="B33">2007</xref>). Identification of additional globin types (GbX, GbE, and GbY) with unknown physiological functions (cit. Burmeister and Hankeln, <xref ref-type="bibr" rid="B11">2014</xref>) has further complicated understanding of the globin gene family evolution. Phylogenetic analysis of vertebrate globins indicate that erythroid-specific globin has independently evolved O<sub>2</sub>&#x02212;transport functions in different lineages (Burmeister and Hankeln, <xref ref-type="bibr" rid="B11">2014</xref>). It has also become evident that vertebrate, plant, and other metazoan Hb&#x00027;s with a classical 3/3 &#x003B1;-helical fold may share a common ancestor with one of three bacterial globin types (Laberge and Yonetani, <xref ref-type="bibr" rid="B34">2007</xref>; Burmeister and Hankeln, <xref ref-type="bibr" rid="B11">2014</xref>).</p>
<p>When erythrocytes are hydrolyzed and the hemolysate rinsed, some Hb remains attached to a bicarbonate/chloride exchanger &#x0201C;band 3&#x0201D; membrane protein, a &#x0201C;multipass&#x0201D; integral component of most cell membranes (e.g., Chu et al., <xref ref-type="bibr" rid="B14">2008</xref>). The nature of the attachment of Hb to &#x0201C;band 3&#x0201D; is not defined. &#x0201C;Band 3&#x0201D; is an important structural protein of the erythrocyte cell membrane, making up 25% of the cell membrane surface (Chu et al., <xref ref-type="bibr" rid="B14">2008</xref>) but has not been associated with globins other than hemoglobin. However, its wide cellular distribution suggests that &#x0201C;band 3&#x0201D; may play an important anion exchanger role in heme systems other than the erythrocyte.</p>
<p>In this study, we analyze the internal cavities and/or channels using computation Methods such as the PoreWalker algorithm (Pellegrini-Calace et al., <xref ref-type="bibr" rid="B52">2009</xref>) and compare the cavity topology with that of the transmembrane helices, the pore-lining regions (Nugent and Jones, <xref ref-type="bibr" rid="B47">2012</xref>), and the cholesterol binding (CRAC/CARC) domains (Li and Papadopoulos, <xref ref-type="bibr" rid="B37">1998</xref>; Baier et al., <xref ref-type="bibr" rid="B4">2011</xref>; Fantini et al., <xref ref-type="bibr" rid="B23">2016</xref>) in closely related members of the extended <italic>Homo sapiens</italic> globin family: Cygb, Ngb, Mb, and Hb subunits &#x003B1; and &#x003B2;. We find that each globin contains either one transmembrane helix or one pore-lining channel-forming amino acid sequence in the C-terminal region as well as one or more internal cavities. The pore-lining regions, TM helices, and cavities coexist in combination with caveolin-binding motifs and/or cholesterol-binding (CRAC/CARC) motifs that provide an environment in which membrane cholesterol levels regulate ion channel formation.</p>
</sec>
<sec sec-type="materials and methods" id="s2">
<title>Materials and methods</title>
<sec>
<title>Materials</title>
<p>The amino acid sequences of <italic>H. sapiens</italic> cytoglobin (Accession <ext-link ext-link-type="DDBJ/EMBL/GenBank" xlink:href="&#x00023;Q8WWM9">&#x00023;Q8WWM9</ext-link>), neuroglobin (Accession <ext-link ext-link-type="DDBJ/EMBL/GenBank" xlink:href="&#x00023;Q9NPG2">&#x00023;Q9NPG2</ext-link>), myoglobin (Accession <ext-link ext-link-type="DDBJ/EMBL/GenBank" xlink:href="&#x00023;P02144">&#x00023;P02144</ext-link>), and hemoglobin subunits alpha (Accession <ext-link ext-link-type="DDBJ/EMBL/GenBank" xlink:href="&#x00023;P69905">&#x00023;P69905</ext-link>), and beta (Accession <ext-link ext-link-type="DDBJ/EMBL/GenBank" xlink:href="&#x00023;P68871">&#x00023;P68871</ext-link>) were downloaded from the ExPASy Proteonomic Server of the Swiss Institute of Bioinfomatics (<ext-link ext-link-type="uri" xlink:href="http://www.expasy.org">http://www.expasy.org</ext-link>; <ext-link ext-link-type="uri" xlink:href="http://www.uniprot.org">http://www.uniprot.org</ext-link>). About 98% of the protein sequences provided by UniProtKB are derived from the translation of the coding sequences (CDS) which have been submitted to the public nucleic acid databases, the EMBL-Bank/Genbank/DDBJ databases (INSDC). Amino acid sequences were compared using the Pairwise Sequence Alignment software (LALIGN) at <ext-link ext-link-type="uri" xlink:href="http://www.ebi.ac.uk/Tools/services/weblalign/">http://www.ebi.ac.uk/Tools/services/weblalign/</ext-link> to find internal duplications by calculating non-intersecting local alignments. The Emboss Water protocol (version 36.3.5e Nov, 2012; preload8) used here employs the Smith-Waterman algorithm (with modified enhancements) to calculate the local alignment of two sequences.</p>
</sec>
<sec>
<title>Secondary structure, transmembrane helix, and pore-lining region predictions</title>
<p>PSIPRED is a simple and accurate secondary structure prediction method, incorporating two feed-forward neural networks which perform an output obtained from Position Specific Iterated&#x02014;Blast. PSIPRED 3.2 achieves an average Q3 score of 81.6% (Nugent et al., <xref ref-type="bibr" rid="B48">2011</xref>) and is available at <ext-link ext-link-type="uri" xlink:href="http://bioinf.cs.ucl.ac.uk/psipred/">http://bioinf.cs.ucl.ac.uk/psipred/</ext-link>. Alpha-helical transmembrane (TM) channel proteins play key roles in a variety of cellular processes essential in movement of ions and molecules across membrane lipid bilayers. As noted by Nugent and Jones (<xref ref-type="bibr" rid="B47">2012</xref>), technical difficulties in obtaining high quality crystals have led to an under-representation of channel proteins in structural databases. These workers have trained a support vector machine classifier to predict the likelihood of a TM helix being involved in pore formation. This approach has a prediction accuracy of 72%, while a support vector regression model is able to predict the number of subunits participating in the pore with 62% accuracy. Pore-lining regions in transmembrane protein sequences in this study were predicted using the method of Nugent and Jones (<xref ref-type="bibr" rid="B47">2012</xref>).</p>
<p>The Consensus Constrained TOPology prediction (CCTOP; <ext-link ext-link-type="uri" xlink:href="http://cctop.enzim.ttk.mta.hu">http://cctop.enzim.ttk.mta.hu</ext-link>) server is a web-based application providing transmembrane topology prediction. In addition to utilizing 10 different state-of-the-art topology prediction methods, the CCTOP server incorporates topology information from existing experimental and computational sources available in the PDBTM, TOPDB, and TODOM data bases using the probabilistic framework of hidden Markov model (Dobson et al., <xref ref-type="bibr" rid="B19">2015</xref>).</p>
<p>Based on X-ray crystallography data (PDB files), Pellegrini-Calace et al. (<xref ref-type="bibr" rid="B52">2009</xref>) have developed a computational approach (PoreWalker 1.0) for the identification and characterization of channels and cavities in proteins based on their three-dimensional structure. The software is available as a web-based resource at <ext-link ext-link-type="uri" xlink:href="http://www.ebi.ac.uk/thornton-srv/software/PoreWalker/">http://www.ebi.ac.uk/thornton-srv/software/PoreWalker/</ext-link>.</p>
</sec>
<sec>
<title>TMKink: A method to predict transmembrane helix kinks</title>
<p>Meruelo et al. (<xref ref-type="bibr" rid="B43">2011</xref>) have identified distinct residue preferences in kinked vs. non-kinked helices and have exploited these differences and residue conservation to predict kinked helices using a neural network algorithm. The kink predictor, TMKink, is available at <ext-link ext-link-type="uri" xlink:href="http://tmkinkpredictor.mbi.ucla.edu/">http://tmkinkpredictor.mbi.ucla.edu/</ext-link>.</p>
</sec>
<sec>
<title>Caveolin-binding motifs and scaffolding domains</title>
<p>Using a GST-fusion protein containing the caveolin scaffolding domain as a receptor to select peptide ligands from a bacteriophage display library, Covet et al. (<xref ref-type="bibr" rid="B17">1997</xref>) identified at least three related but distinct caveolin binding motifs, &#x003A6;xxxx&#x003A6;xx&#x003A6;, &#x003A6;x&#x003A6;xxxx&#x003A6;, and &#x003A6;x&#x003A6;xxxx&#x003A6;xx&#x003A6; (where &#x003A6; represents an aromatic amino acid, W, Y, or F), that have been shown to interact with caveolin in most proteins. The caveolin scaffolding domain is ascribed a role in the recognition and binding of cholesterol, which is highly concentrated in caveolae and essential for their formation. More precisely, formation of caveolae strictly requires tight binding of caveolin to cholesterol (reviewed in Covet et al., <xref ref-type="bibr" rid="B17">1997</xref>). This functionality is thought to localize to a cholesterol recognition/interaction amino acid consensus motif in residues VTKYWFYR (reviewed in Fantini and Barrantes, <xref ref-type="bibr" rid="B22">2013</xref>) defined as the CRAC motif. Despite its short length, this 20-residue segment appears to incorporate an array of critical functionalities in overlapping sequence elements.</p>
</sec>
<sec>
<title>The CRAC/CARC domains</title>
<p>CRAC is a short linear amino acid motif that mediates binding to cholesterol and stands for <underline>C</underline>holes-terol <underline>R</underline>ecognition/Interaction <underline>A</underline> mino acid <underline>C</underline>onsensus sequence (Li and Papadopoulos, <xref ref-type="bibr" rid="B37">1998</xref>; reviewed in Fantini and Barrantes, <xref ref-type="bibr" rid="B22">2013</xref>). In a C-terminus to N-terminus direction the motif consists of a polar Leu (L) or Val (V) residue, followed by a segment containing 1&#x02013;5 of any residues, followed by a mandatory aromatic Tyr (Y) residue, a segment containing 1&#x02013;5 of any residues, and finally a basic Lys (K) or Arg (R). In the one letter amino acid codes the algorithm is (L/V) &#x02013; X1&#x02013;5 &#x02013; (Y) &#x02013; X1&#x02013;5 &#x02013; (K/R). A second cholesterol recognition domain similar to the CRAC domain (CARC) has been identified (Baier et al., <xref ref-type="bibr" rid="B4">2011</xref>) but exhibits the opposite orientation along the polypeptide chain (&#x0201C;in- verted CRAC&#x0201D;), i.e., (K/R) &#x02013; X1&#x02013;5 &#x02013; (Y/F) &#x02013; X1&#x02013;5 &#x02013; (L/V). CARC is distinct from CRAC in that the central amino acid can be either Y or F.</p>
</sec>
</sec>
<sec sec-type="results" id="s3">
<title>Results</title>
<sec>
<title>Pore-lining regions and transmembrane helices in Cytg, Ngb, Mb, and Hb subunits &#x003B1; and &#x003B2;</title>
<p>Transmembrane (TM) helices and pore-lining regions span a large variety of membrane systems including cell-surface receptors, redox proteins, ion channels, and transporters (reviewed in Hildebrand et al., <xref ref-type="bibr" rid="B31">2006</xref>). TM helices are found to be amino acid sequences with hydrogen-bonded helical configurations, including &#x003B1;-, 3<sub>10</sub>&#x02212; and &#x003C0;-helices. The &#x003B1;-helix is very common; while the 3<sub>10</sub> helix is found at the ends of the &#x003B1;-helix and &#x003C0;-helices are rare. Based on data for 160 transmembrane helices of 15 non-homologous high resolution X-ray protein structures, Hildebrand et al. (<xref ref-type="bibr" rid="B32">2004</xref>) found the average TM helix to be a 17.3 &#x000B1; 3.1 (<italic>SD N</italic> &#x0003D; 160) residues in length. However, it is difficult to obtain a representative sampling of the membrane proteins.</p>
<p>Many membrane proteins have proven to be difficult to crystallize owing to their partially hydrophobic surfaces, flexibility, and lack of stability as well as physiologically bound lipids (reviewed in Carpenter et al., <xref ref-type="bibr" rid="B13">2008</xref>).</p>
<p>Nugent et al. (<xref ref-type="bibr" rid="B48">2011</xref>) have developed a method (MEMSAT-SVM) to predict pore-lining regions in transmembrane (TM) proteins and to distinguish pore-lining regions from TM helices (Nugent and Jones, <xref ref-type="bibr" rid="B47">2012</xref>). Pore-lining regions are usually enriched in negatively (e.g., E, D) or positively charged residues (e.g., K, R, H). Four features were used to train a support vector regression model: sequence length, the number of pore lining residues, with the target value set to the number of subunits contacting the pore within the membrane region. Nugent et al. (<xref ref-type="bibr" rid="B48">2011</xref>) were able to identify pore-lining regions and to predict both the likelihood of transmembrane helices involved in pore (channel) formation and to determine the number of subunits required to form a complete pore or channel. As shown in Figure <xref ref-type="fig" rid="F1">1</xref>, topological analyses of <italic>H. sapiens</italic> Cygb (top), Ngb (upper middle), Mb (middle), Hbb (subunit &#x003B2;, lower middle), and Hba (subunit &#x003B1;, bottom) predict that, with the exception of Hba, each globin contains a 16 residue pore-lining (channel-forming) structure in the C-terminal region of the protein (blue squares). In contrast, Hba contains a 15 residue TM helix (black squares). Typically, channel proteins contain a cavity (or pore) which spans the entire membrane protein with an opening on each side of the membrane. The pore often runs parallel to TM helices, forming a path along which ions or molecules travel, with adjacent structural features determining pore specificity. As shown in Figure <xref ref-type="fig" rid="F1">1</xref>, the N-terminal region of both Cygb and Mb was predicted to be extracellular (orange boxes) whereas the N-terminal region of Ngb and the Hba and Hbb subunits is cytoplasmic (white boxes).</p>
<fig id="F1" position="float">
<label>Figure 1</label>
<caption><p><bold>An analysis of the topology of <italic><bold>Homo sapiens</bold></italic> cytoglobin (upper plot, Accession &#x00023;Q8WWM9), neuroglobin (second down, Accession &#x00023;Q9NPG2), myoglobin (third down, Accession &#x00023;P02144), hemoglobin subunit &#x003B2; (forth down, Accession &#x00023;P68871), and hemoglobin subunit &#x003B1; (lower plot, Accession &#x00023;P69905) using the support vector machine-based TM topology predictor MEMSAT-SVM (see Section Methods)</bold>. Transmembrane pore-lining regions are highlighted in blue, whereas transmembrane helices are highlighted in black. White sequences indicate predicted cytoplasmic regions; those highlighted in orange represent extracellular regions. Amino acid sequences are those published in the Swiss Protein Knowledgebase (<ext-link ext-link-type="uri" xlink:href="http://www.uniprot.org">www.uniprot.org</ext-link>). See Section Methods for details.</p></caption>
<graphic xlink:href="fphys-07-00360-g0001.tif"/>
</fig>
<p>Figure <xref ref-type="fig" rid="F2">2</xref> compares the topology for Hba (upper panel) and Hbb (lower panel) using the Consensus Constrained TOPology server (Dobson et al., <xref ref-type="bibr" rid="B19">2015</xref>). Colors are based on the localization of peptide sequences: gray (transit sequence), black (signal peptide), blue (extracytosolic), red (cytosolic), yellow (transmembrane), and orange (re-entrant loop regions). CCTOP analysis of Hba predicts a TM helix in the 100&#x02013;120 residues region, consistent with that shown by the MEMSAT-SVM algorithm in Figure <xref ref-type="fig" rid="F1">1</xref>. Similar TM helices were predicted by the Octopus, Prodiv, and Scampi algorithms. In contrast, CCTOP analysis of Hbb predicted a helix-turn-helix in the 20&#x02013;56 residue region but failed to detect pore-lining regions in the C-terminal region. The findings in Figures <xref ref-type="fig" rid="F1">1</xref>, <xref ref-type="fig" rid="F2">2</xref> suggest that Cygb, Ngb, Hba, and Hbb, as well as Hba (Shaklai et al., <xref ref-type="bibr" rid="B60">1977</xref>), may also be integral to cell membranes.</p>
<fig id="F2" position="float">
<label>Figure 2</label>
<caption><p><bold>An analysis of the topology of <italic><bold>Homo sapiens</bold></italic> hemoglobin subunit &#x003B1; (upper panel) and hemoglobin subunit &#x003B2; (lower panel) using the Consensus Constrained TOPology prediction web server (see Section Methods)</bold>. The Figure <xref ref-type="fig" rid="F1">1</xref> shows the amino acid sequence as colored by the consensus topology. Colors are based on the localization: gray (transit sequence), black (signal peptide), blue (extracytosolic), red (cytosolic), yellow (membrane), and orange (re-entrant loop regions).</p></caption>
<graphic xlink:href="fphys-07-00360-g0002.tif"/>
</fig>
<p>Cybg, Ngb, Mb, Hba, and Mbb amino acid sequences were compared using LALIGHN (see Section Methods). As shown in Table <xref ref-type="table" rid="T1">1</xref>, a comparison of <italic>H. sapiens</italic> Cybg and Ngb indicates a 29.4% identity (63.4% similar) in a 154 amino acid overlap (19&#x02013;171: 3&#x02013;152) with a Waterman:Eggert score of 251. A similar comparison of Cybg and Mb indicates a 28.9% identity (63.1% similar) in a 149 amino acid overlap (19&#x02013;167: 3&#x02013;142) with a Waterman:Eggert score of 227. A comparison of Mb and Hba indicates a 39.3% identity (46.4% similar) with an amino acid overlap of only 28 amino acids (17&#x02013;39: 57&#x02013;84) with a Waterman-Eggert score of only 41. Finally, a comparison of Hba and Hbb indicated a 25.5% identity (58.6% similar) in a 145 amino acid overlap (4&#x02013;146:3&#x02013;147) with a Waterman-Eggert score of 161. Despite the limited amino acid sequence identities and similarities shown here, all four clearly belong to the globin superfamily (Pesce et al., <xref ref-type="bibr" rid="B53">2002</xref>), all contain the typical globin fold (Laberge and Yonetani, <xref ref-type="bibr" rid="B34">2007</xref>) and reversibly bind O2, CO, and NO (reviewed in Pesce et al., <xref ref-type="bibr" rid="B53">2002</xref>). Hb and Mb have been considered almost exclusively as transporters of metabolic gases and nutrients whereas erythrocytes also take up and inactivate endothelium-derived NO to form methemoglobin and nitrate. As noted by Brunori et al. (<xref ref-type="bibr" rid="B9">2005</xref>), Ngb is unlikely to be involved in O2 transport (like Mb) but has been proposed to act as a sensor of the O2/NO ratio in the cell, possibly regulating the GDP/GTP exchange rate, forming a specific complex with the G&#x003B1;<italic>&#x003B2;&#x003B3;</italic>&#x02013;protein when oxidized, but not when bound to a gaseous ligand (reviewed in Chu et al., <xref ref-type="bibr" rid="B14">2008</xref>). Tomita et al. (<xref ref-type="bibr" rid="B66">2009</xref>), using pulsed- laser at cryogenic temperatures to study CO migration in Mb found that the migration of the CO molecule into each cavity induces structural changes of the amino acid residues, resulting in the sequential motion of the ligand, and the cavity. They propose that a breathing motion of internal cavities is a general mechanism of ligand migration.</p>
<table-wrap position="float" id="T1">
<label>Table 1</label>
<caption><p><bold>LALIGN Analysis of <italic><bold>Homo sapiens</bold></italic> Extended Globin Family: Comparison of Cytoglobin, Neuroglobin, Myoglobin, and Hemoglobin Subunits &#x003B1; and &#x003B2;</bold>.</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th valign="top" align="left"><bold>LALIGN analysis</bold></th>
<th valign="top" align="center"><bold>Cyg vs. Ngb</bold></th>
<th valign="top" align="center"><bold>Cyg vs. Mb</bold></th>
<th valign="top" align="center"><bold>Mb vs. Hba</bold></th>
<th valign="top" align="center"><bold>Hba vs. Hbb</bold></th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">% Identical</td>
<td valign="top" align="center">29.4</td>
<td valign="top" align="center">28.9</td>
<td valign="top" align="center">39.3</td>
<td valign="top" align="center">25.5</td>
</tr>
<tr>
<td valign="top" align="left">% Similar</td>
<td valign="top" align="center">63.4</td>
<td valign="top" align="center">63.1</td>
<td valign="top" align="center">46.4</td>
<td valign="top" align="center">58.6</td>
</tr>
<tr>
<td valign="top" align="left">Amino acid overlap</td>
<td valign="top" align="center">154 aa<break/> 19&#x02013;171:3&#x02013;152</td>
<td valign="top" align="center">149 aa<break/> 19&#x02013;167:3&#x02013;142</td>
<td valign="top" align="center">28 aa<break/> 17&#x02013;39:57&#x02013;84</td>
<td valign="top" align="center">145 aa<break/> 4&#x02013;146:3&#x02013;147</td>
</tr>
<tr>
<td valign="top" align="left">Waterman&#x02013;Eggert score</td>
<td valign="top" align="center">251</td>
<td valign="top" align="center">227</td>
<td valign="top" align="center">41</td>
<td valign="top" align="center">161</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec>
<title>Identification and characterization of channels and cavities in Cytg, Ngb, Mb, and Hb</title>
<p>Pellegrini-Calace et al. (<xref ref-type="bibr" rid="B52">2009</xref>) have developed an improved computational approach (PoreWalker 1.0) for the identification and characterization of channels and cavities in proteins, based on their three-dimensional structure. Given a set of 3D crystallography coordinates, this method can detect and identify the pore centers and axis using geometric criteria and the biggest and longest cavity/channel through the protein is identified. Pore features, including diameter profiles, pore-lining residues, the size, shape, and regularity of the pore are used to provide a quantitative and visual characterization of the channel. Since pore-forming proteins interact with lipid bilayers to generate &#x0201C;proteolipidic&#x0201D; pores (Gilbert et al., <xref ref-type="bibr" rid="B25">2014</xref>), the &#x0201C;crystal structure&#x0201D; of a lipid-free protein crystal may not correspond precisely to the physiological cavity/channel.</p>
<p>The left column of Figure <xref ref-type="fig" rid="F3">3</xref> illustrates the PoreWalker structure profiles for Cygb (top), Ngb (upper middle), Mb (lower middle), and Oxy T State Hb (bottom), whereas the right column presents the corresponding pore diameter profiles. The structure profiles are visualizations of a pore section showing pore-lining residues and pore centers, using 3&#x000C0; steps: the section of each structure was obtained by cutting the protein structure along the <italic>xy</italic>-plane, where the <italic>x</italic>-axis corresponds to the pore axis, and the <italic>y</italic>-coordinate &#x0003E;0 only are displayed. The PoreWalker graphics identifies and characterizes the biggest and longest cavity in a set of 3D crystallography coordinates in a cholesterol and lipid-free preparation. The pore-lining atoms and residues are colored in orange and blue, respectively. The remainder of the protein is shown in green. Red spheres represent pore centers at given pore heights and their diameters correspond to 1/10 of the pore diameter calculated at that point. As can be seen in the right hand column, a cavity of varying diameters extends across all four globins. Cygb (1UMO) and Ngb (1OJ6) each contain a sequence of cavities with varying diameters, whereas Mb (3RGK) exhibits a large single cavity localized left (Mb) whereas Oxy Hb (1GZX) contains a large centrally located cavity(s).</p>
<fig id="F3" position="float">
<label>Figure 3</label>
<caption><p><bold>PoreWalker output for <italic><bold>Homo sapiens</bold></italic> cytoglobin (1UMO, top), neuroglobin (IOJ6, second down), myoglobin (3RGK, third down), and hemoglobin (1GZX, bottom)</bold>. Left column is a visualization of a pore section showing pore-lining residues and pore centers at 3&#x000C0; steps; the section of the structure was obtained by cutting the protein structure along the <italic>xy</italic>-plane, where the <italic>x</italic>-axis corresponds to the pore axis, and <italic>y</italic>-coordinate &#x0003E;0 only are displayed. The pore-lining atoms and residues are colored in orange and blue, respectively. The remaining portion of the protein is shown in green. The plots in the right column illustrate the pore diameter profiles at 3&#x000C0; steps.</p></caption>
<graphic xlink:href="fphys-07-00360-g0003.tif"/>
</fig>
<p>Maximum cavity diameters varied from about 6 to 11 angstroms in the 4 globin crystals, or about 3&#x02013;5 times the diameter of a water molecule. The cavities and channels may be larger in fully hydrated proteins embedded in lipid bilayers.</p>
</sec>
<sec>
<title>Putative domain boundaries in human Cygb, Ngb, Mg, and Hbb</title>
<p>The shortest sequence of amino acids in proteins that contains functional and structural information is termed a &#x0201C;motif,&#x0201D; whereas a conserved part of a given protein that can evolve, function, and exist independently is termed a &#x0201C;domain.&#x0201D; Domains and motifs contribute to the structural basis of the physiological functions of proteins and each domain can be considered as a semi-independent structural unit of a protein capable of folding independently (e.g., Batey et al., <xref ref-type="bibr" rid="B6">2008</xref>; Dill et al., <xref ref-type="bibr" rid="B18">2008</xref>; Pang et al., <xref ref-type="bibr" rid="B50">2008</xref>). A variety of different methodologies have been employed to predict domains but many are fraught with problems since domain assignment is difficult even when the structures are known. Bryson et al. (<xref ref-type="bibr" rid="B10">2007</xref>) have developed a useful method for computer-assisted protein domain boundary prediction, using the DomPred server (see Section Methods). This server uses the results from two completely different categories (DPS and DomSSEA). Each is individually compared against one of the latest domain prediction benchmarks to determine their respective reliabilities.</p>
<p>Figure <xref ref-type="fig" rid="F4">4</xref> illustrates a DomPred analysis of the five different globins from <italic>H. sapiens</italic>. As can be seen, the protein domain patterns differ, with the domains of Hba and Hbb being the most complex. As noted by Marsden et al. (<xref ref-type="bibr" rid="B42">2002</xref>), the modular nature of many domains means that they can often be found in proteins with a similar content, but with different orders, or in different proteins in combination with entirely different domain structures. In addition to the TM helices, pore-lining regions, and domain structures described above, functional domains such as CRAC or CARC cholesterol binding motifs (reviewed in Fantini and Barrantes, <xref ref-type="bibr" rid="B22">2013</xref>) can be identified within the Cygb, Ngb, Mb, and Hb subunits &#x003B1; (Hba) and &#x003B2; (Hbb). Figure <xref ref-type="fig" rid="F5">5</xref> compares the distribution of cholesterol-binding (CRAC/CARC) domains (highlighted in red) with caveolin-binding motifs (underlined in blue) and both TM helices (double underlined) and pore-lining regions (single underlined) identified. A cholesterol binding domain similar to CRAC has also been characterized and is termed a &#x0201C;CARC&#x0201D; motif (reviewed in Fantini and Barrantes, <xref ref-type="bibr" rid="B22">2013</xref>). The so- called &#x0201C;CARC motif&#x0201D; is comparable to the CRAC domain but exhibits the opposite orientation along the polypeptide chain (&#x0201C;inverted CRAC&#x0201D;; Baier et al., <xref ref-type="bibr" rid="B4">2011</xref>) and is distinct from CRAC in that the central amino acid can be either Y or F.</p>
<fig id="F4" position="float">
<label>Figure 4</label>
<caption><p><bold>Protein domain and motif sequence analysis of <italic><bold>Homo sapiens</bold></italic> cytoglobin (Cybg Q8WWM9, top), neuroglobin (Ngb Q9NPG2, second from top), Myoglobin (Mb P02144, third from top), hemoglobin subunit &#x003B1; (Hba P69905, bottom left), and hemoglobin subunit &#x003B2; (Hbb P68871, bottom right) as predicted by the DomPred algorihm</bold>.</p></caption>
<graphic xlink:href="fphys-07-00360-g0004.tif"/>
</fig>
<fig id="F5" position="float">
<label>Figure 5</label>
<caption><p><bold>Cholesterol-binding (CRAC/CARC) motif sequence analysis (red highlights) and caveolin distribution (blue underline) in <italic><bold>Homo sapiens</bold></italic> cytoglobin (Cybg Q8WWM9, top), neuroglobin (Ngb Q9NPG2, second from top), Myoglobin (Mb P02144, third from top), hemoglobin subunit &#x003B1; (Hba P69905, second from bottom), and hemoglobin subunit &#x003B2; (Hbb P68871, bottom)</bold>. CRAC/CARC motifs are indicated by red highlighting and caveolin binding motifs are underlined in blue. Pore-lining regions are single underlined in black. TM helices are indicated by double underlining.</p></caption>
<graphic xlink:href="fphys-07-00360-g0005.tif"/>
</fig>
<p>Molecular modeling studies have shown that CRAC/CARC motifs have a good fit for cholesterol (cit. Fantini and Barrantes, <xref ref-type="bibr" rid="B22">2013</xref>). Although cholesterol is concentrated in sphingolipid-enriched membrane microdomains such as &#x0201C;lipid rafts&#x0201D; (Silvius, <xref ref-type="bibr" rid="B62">2003</xref>), it is also present in the lipid disordered phase of the plasma membrane that contains high amounts of glycerolphospholipids such as phosphatidylcholine (Heberle and Feigenson, <xref ref-type="bibr" rid="B30">2011</xref>). Artificial lipid membranes also contain rather large voids, the volume of which can be an order of magnitude larger than the largest spherical cavities present in biological membranes (Alinchenko et al., <xref ref-type="bibr" rid="B1">2005</xref>). Studies have shown that addition of cholesterol to artificial lipid membranes produces elongated voids lying perfectly parallel with the membrane in normal axis (Alinchenko et al., <xref ref-type="bibr" rid="B1">2005</xref>), reminiscent of the cavities shown for globins (see Figure <xref ref-type="fig" rid="F3">3</xref>).</p>
</sec>
<sec>
<title>Cholesterol-binding sites within globin cavities and channels</title>
<p>Since the PoreWalker algorithm identifies both the amino acid residues and/or domains lining the largest cavity within each globin, it is possible to identify potential cholesterol binding (CRAC/CARC) sites lining the globin cavities. Caveolin (blue underline in Figure <xref ref-type="fig" rid="F5">5</xref>) is an unusual protein that can exist both as an integral membrane protein and as a soluble protein in multiple cell compartments (reviewed in Liu et al., <xref ref-type="bibr" rid="B40">2002</xref>). As shown, Ngb and Hbb each contain a caveolin binding motif (<sup>42</sup>FQYNCRQF<sup>49</sup> and <sup>36</sup>YPWTQRFFESF<sup>46</sup>) overlapping CRAC/CARC motifs. Topological analysis of all three isoforms of <italic>H. sapiens</italic> caveolin indicates that each caveolin molecule also contains a pore-lining region, a TM helix-turn-TM helix, and a CRAC/CARC motif (Morrill et al., <xref ref-type="bibr" rid="B46">2014</xref>). Thus, the presence of CRAC/CARC motifs as well as pore-lining regions within the caveolins in proximity to either the pore-lining regions or TM helices in Ngb and Hba could contribute to channel formation.</p>
<p>As shown in Figure <xref ref-type="fig" rid="F5">5</xref>, two to six CRAC/CARC domains are associated with the Cybg, Ngb, Mb, Hba, and Hbb monomers. Only Cybg (top) and Hbb (bottom) exhibit pore-lining regions with minimal (one residue) overlapping CRAC/CARC motifs. The Cybg dimer would contain up to 6 bound cholesterol molecules whereas the Hb tetramer would contain up to 14 bound cholesterols. Judging from the topology for Cybg and Hbb shown in Figure <xref ref-type="fig" rid="F1">1</xref>, the CRAC/CARC motifs are at the protein surface and may involve surface docking sites (e.g., Listowski et al., <xref ref-type="bibr" rid="B39">2015</xref>). However, since removal of cholesterol and/or other lipids is often essential in obtaining protein crystals (reviewed in Carpenter et al., <xref ref-type="bibr" rid="B13">2008</xref>), the protein data base for globin preparations used in x-ray crystallographic analysis list only globin, heme and sulfate or phosphate ions. Cholesterol, phospholipids and water in kinks have been removed.</p>
<p>Similarly, it should be noted that Hb used in biophysical studies (e.g., Roche et al., <xref ref-type="bibr" rid="B55">2013</xref>) has been prepared by anion exchange chromatography methods (Andrade et al., <xref ref-type="bibr" rid="B3">2004</xref>) that largely removes endogenous lipids and may thus alter the physiological properties of the Hb molecule.</p>
<p>It should also be noted that methionine is the N-terminal amino acid in each of the 5 globins shown in Figure <xref ref-type="fig" rid="F5">5</xref>. In a biological system, protein synthesis is initiated universally with the amino acid methionine (see Drabkin and RajBhandary, <xref ref-type="bibr" rid="B21">1998</xref>) which is subsequently removed by enzymes in the cell. Since x-ray crystallography methods require large quantities of a pure protein (Watanabe et al., <xref ref-type="bibr" rid="B68">2010</xref>), crystallography pdb files of cell-free preparations such as those analyzed by PoreWalker (Figure <xref ref-type="fig" rid="F3">3</xref>) contain N-terminal methionine. The codon initiator methionine is therefore listed in Figure <xref ref-type="fig" rid="F5">5</xref>, although it may not be present physiologically. A contribution from N-terminal methionine to the crystallographic structure has not been ruled out.</p>
</sec>
<sec>
<title>Correlation of glycosylation with cholesterol binding (CRAC/CARC) motifs</title>
<p>Most plasma membrane and secretory proteins contain one or more carbohydrate chains and the addition and subsequent processing of carbohydrates is the principal chemical modification of such proteins (Cit. Moremen et al., <xref ref-type="bibr" rid="B45">2012</xref>). Glucose reacts non-enzymatically with &#x003B1;- and &#x003B5;-amino groups on proteins <italic>in vitro</italic> and was shown to occur <italic>in vivo</italic> with the discovery of a naturally existing human Hb component, Hb A1c (Shapiro et al., <xref ref-type="bibr" rid="B61">1980</xref>). Hb glycosylation is elevated in patients with diabetes mellitus, reflective of the increased blood glucose levels. The major Hb glycosylation sites <italic>in vitro</italic> and <italic>in vivo</italic> include &#x003B2;-Lys(K)-66 and &#x003B2;-Lys(K)-120. As shown in Figure <xref ref-type="fig" rid="F5">5</xref>, after correcting for the initiator methionine, Lys<sup>66</sup> and Lys<sup>120</sup> occur in two of the four Hbb CRAC/CARC motifs. This suggests that insulin directly affects cholesterol binding to the Hb &#x003B2; subunit. Mb is similar to the &#x003B2;-chain of hemoglobin (Hbb) and has a sufficient number of &#x003B5;-amino groups to be glycosylated like Hbb. Banerjee and Chakraborti (<xref ref-type="bibr" rid="B5">2014</xref>) have shown that glyoxal, a highly reactive oxoaldehyde, is elevated in diabetes and modifies Lys<sup>145</sup> (a residue within one of two Mb CRAC/CARC motifs), suggesting that insulin may also effect Mb function.</p>
<p>A link between insulin and cholesterol binding is also demonstrated by the finding that, under hypoglycemic conditions, hyperinsulinism causes an increase in cholesterol binding to Hb (Tomasevic et al., <xref ref-type="bibr" rid="B65">2003</xref>). Using a fluorescent lipid analog, these workers have shown that lipid internalization occurs in erythrocytes in response to elevated insulin levels. A further link between glycosylation and diabetes is the report that glycosylation <italic>per-se</italic> leads to blood pressure reduction in type 2 diabetics patients untreated for hypertension (Cabrales et al., <xref ref-type="bibr" rid="B12">2008</xref>).</p>
</sec>
<sec>
<title>Characterization of the Hb binding site on the erythrocyte membrane</title>
<p>There is a long history concerned with Hb binding sites on the red cell membrane (see Shaklai et al., <xref ref-type="bibr" rid="B60">1977</xref>). Current evidence indicates that anion exchange protein &#x0201C;band 3,&#x0201D; a multipass membrane protein, is the major membrane binding site for Hb in the human erythrocyte (e.g., Chu et al., <xref ref-type="bibr" rid="B14">2008</xref>). The bicarbonate/chloride exchanger &#x0201C;band 3&#x0201D; (Anion Exchanger, AE1) is an important structural protein in the erythrocyte cell membrane (van den Akker et al., <xref ref-type="bibr" rid="B67">2010</xref>). Each human erythrocyte is estimated to contain 1 million copies of &#x0201C;band 3.&#x0201D; &#x0201C;Band 3&#x0201D; is also thought to play an important role in transmembrane gas exchange and function as a point of attachment for the cytoskeletons that maintain the osmotic properties of the cell (cit. van den Akker et al., <xref ref-type="bibr" rid="B67">2010</xref>). The oxygenation state of Hb also plays an important role, since deoxyhemoglobin, but not oxyhemoglobin, binds &#x0201C;band 3&#x0201D; reversibly with high affinity (van den Akker et al., <xref ref-type="bibr" rid="B67">2010</xref>).</p>
<p>Figure <xref ref-type="fig" rid="F6">6</xref> demonstrates that <italic>H. sapiens</italic> &#x0201C;band 3&#x0201D; (Accession &#x00023;P48751) contains a large central cavity (Figures <xref ref-type="fig" rid="F6">6A,B</xref>) as well as 12 transmembrane helices located in the C-terminal region. The 705 N-terminal residues are extracellular with the subsequent 491 residues containing 12 closely packed helices and/or pore-lining regions. The five helices indicated by blue squares (2, 4, 6, 8, 10) are predicted to be pore-lining regions (Figure <xref ref-type="fig" rid="F6">6C</xref>). It should also be noted that about half of all transmembrane helices contain bends and other deviations often referred to as &#x0201C;kinks&#x0201D; (reviewed in Meruelo et al., <xref ref-type="bibr" rid="B43">2011</xref>). As proposed by Meruelo et al. (<xref ref-type="bibr" rid="B43">2011</xref>), distortions in helix geometry may facilitate conformational changes required for protein function by providing sites of flexibility and can be important for positioning key residues precisely in the protein structure. Kinks that open the polar backbone to alternative hydrogen bonds often attract water molecules, thus providing a polar region within the hydrophobic core (Hall et al., <xref ref-type="bibr" rid="B27">2009</xref>). TMkink analysis indicates that TM-1 of &#x0201C;band 3&#x0201D; contains a large kink (<sup>710</sup>A &#x02013; A<sup>723</sup>), thus providing a potential polar-water filled region. Anion exchange protein &#x0201C;band 3&#x0201D; thus contains numerous pore-lining regions as well as a water-containing kink suggesting that the anion exchange protein (&#x0201C;band 3&#x0201D;) may merge with pore-lining regions in hemoglobin molecules to form bicarbonate/chloride exchange channels (see Hildebrand et al., <xref ref-type="bibr" rid="B31">2006</xref>; Nugent and Jones, <xref ref-type="bibr" rid="B47">2012</xref> for discussion of channel/pore formation).</p>
<fig id="F6" position="float">
<label>Figure 6</label>
<caption><p><bold>An analysis of the MEMSAT-SVM topology and PoreWalker prediction for anion exchange &#x0201C;protein 3&#x0201D; (<italic><bold>Homo sapiens</bold></italic>, Accession &#x00023;P48751)</bold>. Panel <bold>(A)</bold> represents PoreWalker output for &#x0201C;protein 3&#x0201D; pdb B3A3 (top left). Panel <bold>(B)</bold> illustrates the pore diameter profile at 3&#x000C0; steps. Panel <bold>(C)</bold> represents the topology using the support vector machine-based TM topology predictor (see Section Methods). Transmembrane pore-lining regions are highlighted in blue, whereas transmembrane helices are highlighted in black. White sequences indicate predicted cytoplasmic regions; those highlighted in orange represent extracellular regions.</p></caption>
<graphic xlink:href="fphys-07-00360-g0006.tif"/>
</fig>
</sec>
<sec>
<title>Comparison of features of the cavities in Cybg, Ngb, Mb, and the Hb tetramer</title>
<p>The regularity of the pore cavity is deduced from the positions of the pore centers calculated by PoreWalker, aimed at the optimization of the pore axis. If all the pore centers within a channel are co-linear, then the pore is linear and the cavity is symmetrical. If a pore centers in only certain areas of the channel, but not the entire channel, and are co-linear, the cavity will be non-symmetric, and the channel irregular. Figure <xref ref-type="fig" rid="F7">7</xref> compares the protein orientation of Cybg (top), Ngb (upper middle), Mb (lower middle), and Hb (bottom) for the <italic>XZ</italic> plane section when Y &#x0003E; 0 coordinates only. Cybg exists as a dimer, Ngb and Mb are monomers and Hb is a 4-mer (ABAB). As noted above, cholesterol and other lipids have been removed prior to crystal formation. The lowest coordinate is along the pore axis (&#x0003D;<italic>x</italic>-axis) at the bottom. The red spheres represent pore centers at 1 &#x000C0; steps along the pore axis. Cavities traverse each globin, indicating that all four globins without bound cholesterol contain a single major continuous pore or channel.</p>
<fig id="F7" position="float">
<label>Figure 7</label>
<caption><p><bold>A comparison of the pore diameter profiles for cytoglobin (upper plot, 1UMO), neuroglobin (upper middle plot, 1OJ6), myoglobin (lower middle plot, 3RGK), and hemoglobin (lower plot, 1A00) using the PoreWalker algorithm (Pellegrini-Calace et al., <xref ref-type="bibr" rid="B52">2009</xref>)</bold>. For details see Section Methods.</p></caption>
<graphic xlink:href="fphys-07-00360-g0007.tif"/>
</fig>
<p>Table <xref ref-type="table" rid="T2">2</xref> identifies distal and proximal Fe sites for Cybg, Ngb, Mb, and Mbb at the top of each column and underlines the cavity-lining Fe binding sites within Cybg (<sup>113</sup>H, heme proximal ligand), Ngb (<sup>96</sup>H, heme proximal ligand), Mb (<sup>65</sup>H, heme distal ligand), and Hbb (<sup>64</sup>H, heme distal ligand). The cavity-lining Fe binding site for Hba was <sup>88</sup>H, heme proximal ligand (data not shown). Cavity-lining residues are defined as amino acids contributing at least one atom to the inside surface of the pore. The pore surface can be considered as a continuum made up of horizontal and vertical layers of atoms. As also shown in Table <xref ref-type="table" rid="T2">2</xref>, the cavity-lining regions involve 57 of 190 Cybg residues, 38 of 151 of Ngb residues, 55 of the 154 Mb residues, or 35 of 144 residues in Hbb (subunit &#x003B2;). Residues associated with cholesterol binding (CRAC, CARC) motifs are highlighted in red. As indicated, each globin contains one or more bound cholesterol molecule within the predicted cavity and/or channel. For comparison, Table <xref ref-type="table" rid="T3">3</xref> compares the specific residues within the pore-lining regions that correspond to the cavity-lining residues identified by PoreWalker. Ten pore-lining residues within Cybg correspond to cavity-lining residues identified by PoreWalker. Similarly, 9 pore-lining residues are within the cavity of Ngb, and 10 and 8 residues were within the cavities of Mb and Hbb, respectively. Many of the residues identified by PoreWalker as pore-lining residues were confirmed as accessible to water (hydrophilic sites) using a water accessibility predictor (Lingwood et al., <xref ref-type="bibr" rid="B38">2009</xref>) for &#x003B1;-helical transmembrane proteins (MPRAP).</p>
<table-wrap position="float" id="T2">
<label>Table 2</label>
<caption><p><bold>Comparison of the predicted cavity-lining residues in cytoglobin, neuroglobin, myoglobin, and hemoglobin &#x003B2; using PoreWalker analysis: red highlights indicate CRAC/CARC binding sites</bold>.</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th valign="top" align="center" colspan="2"><bold>Cytoglobin (Cybg) Fe binding sites 81, 113</bold></th>
<th valign="top" align="center" colspan="2"><bold>Neuroglobin (Ngb) Fe binding sites 64, 96</bold></th>
<th valign="top" align="center" colspan="2"><bold>Myoglobin (Mb) Fe binding sites 65, 94</bold></th>
<th valign="top" align="center" colspan="2"><bold>Hemoglobin</bold> &#x003B2; <bold>(Mbb) Fe binding sites 64, 93</bold></th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="center">18</td>
<td valign="top" align="center">102</td>
<td valign="top" align="center">3</td>
<td valign="top" align="center">104</td>
<td valign="top" align="center">9</td>
<td valign="top" align="center">93</td>
<td valign="top" align="center">15</td>
<td valign="top" align="center">101</td>
</tr>
<tr>
<td valign="top" align="center">19</td>
<td/>
<td/>
<td valign="top" align="center">105</td>
<td/>
<td/>
<td/>
<td valign="top" align="center">102</td>
</tr>
<tr>
<td valign="top" align="center">20</td>
<td valign="top" align="center">106</td>
<td valign="top" align="center">67</td>
<td/>
<td valign="top" align="center">12</td>
<td valign="top" align="center">99</td>
<td valign="top" align="center">19</td>
<td valign="top" align="center">104</td>
</tr>
<tr>
<td/>
<td valign="top" align="center">109</td>
<td valign="top" align="center">68</td>
<td/>
<td valign="top" align="center">13</td>
<td/>
<td/>
<td valign="top" align="center">105</td>
</tr>
<tr>
<td valign="top" align="center">23</td>
<td valign="top" align="center">111</td>
<td valign="top" align="center">71</td>
<td valign="top" align="center">109</td>
<td valign="top" align="center">14</td>
<td valign="top" align="center">100</td>
<td valign="top" align="center">22</td>
<td valign="top" align="center">108</td>
</tr>
<tr>
<td valign="top" align="center">24</td>
<td valign="top" align="center">113</td>
<td valign="top" align="center">72</td>
<td/>
<td/>
<td valign="top" align="center">101</td>
<td/>
<td valign="top" align="center">109</td>
</tr>
<tr>
<td/>
<td/>
<td valign="top" align="center">73</td>
<td valign="top" align="center">114</td>
<td valign="top" align="center">16</td>
<td valign="top" align="center">103</td>
<td valign="top" align="center">25</td>
<td/>
</tr>
<tr>
<td valign="top" align="center">27</td>
<td/>
<td valign="top" align="center">74</td>
<td/>
<td valign="top" align="center">17</td>
<td valign="top" align="center">104</td>
<td valign="top" align="center">26</td>
<td valign="top" align="center">112</td>
</tr>
<tr>
<td valign="top" align="center">28</td>
<td valign="top" align="center" style="color:#ed1c24">122</td>
<td valign="top" align="center">75</td>
<td/>
<td valign="top" align="center">20</td>
<td valign="top" align="center">107</td>
<td valign="top" align="center">27</td>
<td valign="top" align="center">113</td>
</tr>
<tr>
<td valign="top" align="center">30</td>
<td valign="top" align="center" style="color:#ed1c24">124</td>
<td valign="top" align="center">78</td>
<td valign="top" align="center">133</td>
<td valign="top" align="center">21</td>
<td valign="top" align="center">108</td>
<td/>
<td valign="top" align="center">115</td>
</tr>
<tr>
<td valign="top" align="center">31</td>
<td valign="top" align="center" style="color:#ed1c24">125</td>
<td valign="top" align="center">79</td>
<td/>
<td valign="top" align="center">24</td>
<td valign="top" align="center">110</td>
<td valign="top" align="center">30</td>
<td valign="top" align="center">116</td>
</tr>
<tr>
<td valign="top" align="center" style="color:#ed1c24">34</td>
<td valign="top" align="center">126</td>
<td/>
<td valign="top" align="center">136</td>
<td valign="top" align="center">25</td>
<td valign="top" align="center">111</td>
<td valign="top" align="center" style="color:#ed1c24">31</td>
<td valign="top" align="center">117</td>
</tr>
<tr>
<td/>
<td/>
<td valign="top" align="center">81</td>
<td valign="top" align="center">137</td>
<td valign="top" align="center">27</td>
<td/>
<td valign="top" align="center" style="color:#ed1c24">33</td>
<td/>
</tr>
<tr>
<td valign="top" align="center" style="color:#ed1c24">37</td>
<td valign="top" align="center">128</td>
<td valign="top" align="center">82</td>
<td/>
<td valign="top" align="center">28</td>
<td valign="top" align="center">114</td>
<td valign="top" align="center" style="color:#ed1c24">34</td>
<td valign="top" align="center" style="color:#ed1c24">131</td>
</tr>
<tr>
<td valign="top" align="center" style="color:#ed1c24">38</td>
<td valign="top" align="center">129</td>
<td valign="top" align="center">83</td>
<td valign="top" align="center">139</td>
<td valign="top" align="center">29</td>
<td valign="top" align="center">115</td>
<td valign="top" align="center" style="color:#ed1c24">35</td>
<td valign="top" align="center" style="color:#ed1c24">132</td>
</tr>
<tr>
<td/>
<td valign="top" align="center">130</td>
<td valign="top" align="center">84</td>
<td valign="top" align="center">140</td>
<td/>
<td valign="top" align="center">118</td>
<td valign="top" align="center" style="color:#ed1c24">37</td>
<td/>
</tr>
<tr>
<td valign="top" align="center">48</td>
<td valign="top" align="center">131</td>
<td valign="top" align="center" style="color:#ed1c24">85</td>
<td valign="top" align="center">141</td>
<td valign="top" align="center">31</td>
<td valign="top" align="center">119</td>
<td/>
<td valign="top" align="center">134</td>
</tr>
<tr>
<td valign="top" align="center">49</td>
<td valign="top" align="center">132</td>
<td valign="top" align="center" style="color:#ed1c24">86</td>
<td valign="top" align="center">142</td>
<td valign="top" align="center">32</td>
<td valign="top" align="center">120</td>
<td valign="top" align="center">52</td>
<td valign="top" align="center">135</td>
</tr>
<tr>
<td/>
<td valign="top" align="center">133</td>
<td valign="top" align="center" style="color:#ed1c24">87</td>
<td/>
<td/>
<td valign="top" align="center">122</td>
<td/>
<td/>
</tr>
<tr>
<td valign="top" align="center">52</td>
<td valign="top" align="center">134</td>
<td valign="top" align="center" style="color:#ed1c24">88</td>
<td valign="top" align="center">144</td>
<td valign="top" align="center" style="color:#ed1c24">43</td>
<td valign="top" align="center">123</td>
<td valign="top" align="center">55</td>
<td valign="top" align="center">139</td>
</tr>
<tr>
<td valign="top" align="center">53</td>
<td valign="top" align="center">135</td>
<td valign="top" align="center" style="color:#ed1c24">89</td>
<td/>
<td/>
<td/>
<td/>
<td/>
</tr>
<tr>
<td/>
<td/>
<td valign="top" align="center" style="color:#ed1c24">90</td>
<td valign="top" align="center">146</td>
<td valign="top" align="center">64</td>
<td valign="top" align="center">131</td>
<td valign="top" align="center">61</td>
<td valign="top" align="center">143</td>
</tr>
<tr>
<td valign="top" align="center">54</td>
<td valign="top" align="center">143</td>
<td valign="top" align="center" style="color:#ed1c24">91</td>
<td/>
<td valign="top" align="center">65</td>
<td valign="top" align="center">132</td>
<td/>
<td/>
</tr>
<tr>
<td valign="top" align="center">55</td>
<td valign="top" align="center">148</td>
<td valign="top" align="center" style="color:#ed1c24">92</td>
<td/>
<td valign="top" align="center">66</td>
<td valign="top" align="center">134</td>
<td valign="top" align="center">64</td>
<td/>
</tr>
<tr>
<td/>
<td/>
<td valign="top" align="center">94</td>
<td/>
<td valign="top" align="center">68</td>
<td valign="top" align="center">135</td>
<td/>
<td/>
</tr>
<tr>
<td valign="top" align="center">67</td>
<td valign="top" align="center">150</td>
<td valign="top" align="center">95</td>
<td/>
<td valign="top" align="center">69</td>
<td/>
<td valign="top" align="center">68</td>
<td/>
</tr>
<tr>
<td/>
<td valign="top" align="center">151</td>
<td valign="top" align="center">96</td>
<td/>
<td/>
<td valign="top" align="center">138</td>
<td/>
<td/>
</tr>
<tr>
<td valign="top" align="center">84</td>
<td valign="top" align="center">152</td>
<td/>
<td/>
<td valign="top" align="center">72</td>
<td valign="top" align="center">139</td>
<td valign="top" align="center">77</td>
<td/>
</tr>
<tr>
<td valign="top" align="center">86</td>
<td valign="top" align="center">153</td>
<td/>
<td/>
<td valign="top" align="center">75</td>
<td/>
<td/>
<td/>
</tr>
<tr>
<td valign="top" align="center">89</td>
<td valign="top" align="center">154</td>
<td/>
<td/>
<td valign="top" align="center">76</td>
<td valign="top" align="center" style="color:#ed1c24">142</td>
<td/>
<td/>
</tr>
<tr>
<td/>
<td valign="top" align="center" style="color:#ed1c24">155</td>
<td/>
<td/>
<td/>
<td valign="top" align="center" style="color:#ed1c24">143</td>
<td/>
<td/>
</tr>
<tr>
<td valign="top" align="center">92</td>
<td/>
<td/>
<td/>
<td valign="top" align="center">85</td>
<td valign="top" align="center" style="color:#ed1c24">146</td>
<td/>
<td/>
</tr>
<tr>
<td valign="top" align="center">93</td>
<td valign="top" align="center" style="color:#ed1c24">157</td>
<td/>
<td/>
<td valign="top" align="center">86</td>
<td/>
<td/>
<td/>
</tr>
<tr>
<td/>
<td valign="top" align="center" style="color:#ed1c24">158</td>
<td/>
<td/>
<td valign="top" align="center">89</td>
<td/>
<td/>
<td/>
</tr>
<tr>
<td valign="top" align="center">96</td>
<td valign="top" align="center" style="color:#ed1c24">159</td>
<td/>
<td/>
<td/>
<td/>
<td/>
<td/>
</tr>
<tr>
<td/>
<td valign="top" align="center" style="color:#ed1c24">161</td>
<td/>
<td/>
<td/>
<td/>
<td/>
<td/>
</tr>
<tr>
<td valign="top" align="center">99</td>
<td valign="top" align="center" style="color:#ed1c24">162</td>
<td/>
<td/>
<td/>
<td/>
<td/>
<td/>
</tr>
</tbody>
</table>
</table-wrap>
<table-wrap position="float" id="T3">
<label>Table 3</label>
<caption><p><bold>Correlation between cavity-lining residues identified by the PoreWalker Algorithm and Pore-Lining residues predicted by MEMSAT-SVM</bold>.</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th valign="top" align="center" colspan="2" style="border-bottom: thin solid #000000;"><bold>Cytoglobin Q8WWM9</bold></th>
<th valign="top" align="center" colspan="2" style="border-bottom: thin solid #000000;"><bold>Neuroglobin Q9NPG2</bold></th>
<th valign="top" align="center" colspan="2" style="border-bottom: thin solid #000000;"><bold>Myoglobin P02144</bold></th>
<th valign="top" align="center" colspan="2" style="border-bottom: thin solid #000000;"><bold>Hemoglobin &#x003B2; P68871</bold></th>
</tr>
<tr>
<th valign="top" align="center"><bold>Cavity</bold></th>
<th valign="top" align="center"><bold>Pore-lining</bold></th>
<th valign="top" align="center"><bold>Cavity</bold></th>
<th valign="top" align="center"><bold>Pore-lining</bold></th>
<th valign="top" align="center"><bold>Cavity</bold></th>
<th valign="top" align="center"><bold>Pore-lining</bold></th>
<th valign="top" align="center"><bold>Cavity</bold></th>
<th valign="top" align="center"><bold>Pore-lining</bold></th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="center">125</td>
<td valign="top" align="center">125</td>
<td valign="top" align="center">133</td>
<td valign="top" align="center">133</td>
<td valign="top" align="center">104</td>
<td valign="top" align="center">105</td>
<td valign="top" align="center">105</td>
<td/>
</tr>
<tr>
<td valign="top" align="center">126</td>
<td valign="top" align="center">126</td>
<td/>
<td valign="top" align="center">134</td>
<td/>
<td valign="top" align="center">106</td>
<td/>
<td valign="top" align="center">106</td>
</tr>
<tr>
<td/>
<td valign="top" align="center">127</td>
<td/>
<td valign="top" align="center">135</td>
<td/>
<td valign="top" align="center">107</td>
<td/>
<td valign="top" align="center">107</td>
</tr>
<tr>
<td valign="top" align="center">128</td>
<td valign="top" align="center">128</td>
<td valign="top" align="center">136</td>
<td valign="top" align="center">136</td>
<td valign="top" align="center">107</td>
<td valign="top" align="center">108</td>
<td valign="top" align="center">108</td>
<td valign="top" align="center">108</td>
</tr>
<tr>
<td valign="top" align="center">129</td>
<td valign="top" align="center">129</td>
<td valign="top" align="center">137</td>
<td valign="top" align="center">137</td>
<td valign="top" align="center">108</td>
<td valign="top" align="center">109</td>
<td valign="top" align="center">109</td>
<td valign="top" align="center">109</td>
</tr>
<tr>
<td valign="top" align="center">130</td>
<td valign="top" align="center">130</td>
<td valign="top" align="center">139</td>
<td valign="top" align="center">138</td>
<td/>
<td valign="top" align="center">110</td>
<td/>
<td valign="top" align="center">110</td>
</tr>
<tr>
<td valign="top" align="center">131</td>
<td valign="top" align="center">131</td>
<td valign="top" align="center">140</td>
<td valign="top" align="center">139</td>
<td valign="top" align="center">110</td>
<td valign="top" align="center">111</td>
<td/>
<td valign="top" align="center">111</td>
</tr>
<tr>
<td valign="top" align="center">132</td>
<td valign="top" align="center">132</td>
<td valign="top" align="center">141</td>
<td valign="top" align="center">140</td>
<td valign="top" align="center">111</td>
<td valign="top" align="center">112</td>
<td valign="top" align="center">112</td>
<td valign="top" align="center">112</td>
</tr>
<tr>
<td valign="top" align="center">133</td>
<td valign="top" align="center">133</td>
<td valign="top" align="center">142</td>
<td valign="top" align="center">141</td>
<td/>
<td valign="top" align="center">113</td>
<td valign="top" align="center">113</td>
<td valign="top" align="center">113</td>
</tr>
<tr>
<td valign="top" align="center">134</td>
<td valign="top" align="center">134</td>
<td/>
<td valign="top" align="center">142</td>
<td/>
<td valign="top" align="center">114</td>
<td/>
<td valign="top" align="center">114</td>
</tr>
<tr>
<td valign="top" align="center">135</td>
<td valign="top" align="center">135</td>
<td valign="top" align="center">144</td>
<td valign="top" align="center">143</td>
<td valign="top" align="center">114</td>
<td valign="top" align="center">115</td>
<td valign="top" align="center">115</td>
<td valign="top" align="center">115</td>
</tr>
<tr>
<td/>
<td valign="top" align="center">136</td>
<td/>
<td valign="top" align="center">144</td>
<td valign="top" align="center">115</td>
<td valign="top" align="center">116</td>
<td valign="top" align="center">116</td>
<td valign="top" align="center">116</td>
</tr>
<tr>
<td/>
<td valign="top" align="center">137</td>
<td valign="top" align="center">146</td>
<td valign="top" align="center">145</td>
<td/>
<td valign="top" align="center">117</td>
<td valign="top" align="center">117</td>
<td valign="top" align="center">117</td>
</tr>
<tr>
<td/>
<td valign="top" align="center">138</td>
<td/>
<td valign="top" align="center">146</td>
<td valign="top" align="center">118</td>
<td valign="top" align="center">118</td>
<td/>
<td valign="top" align="center">118</td>
</tr>
<tr>
<td/>
<td valign="top" align="center">139</td>
<td/>
<td valign="top" align="center">147</td>
<td valign="top" align="center">119</td>
<td valign="top" align="center">119</td>
<td/>
<td valign="top" align="center">119</td>
</tr>
<tr>
<td/>
<td valign="top" align="center">140</td>
<td/>
<td valign="top" align="center">148</td>
<td valign="top" align="center">120</td>
<td valign="top" align="center">120</td>
<td/>
<td valign="top" align="center">120</td>
</tr>
</tbody>
</table>
</table-wrap>
<p>Compared to the dimeric (Cybg) or monomeric forms (Ngb and Mb), Hb is a heterotetramer consisting of two &#x003B1; chains and two &#x003B2; chains. Table <xref ref-type="table" rid="T4">4</xref> compares the predicted cavity-lining residues of the T state Hb heterotetromer (1GZX). Columns A and C represent the two &#x003B1; subunits whereas B and D correspond to the two &#x003B2; subunits. The CRAC/CARC motifs are highlighted in red and the pore-lining or TM helix residues are highlighted in blue. Table <xref ref-type="table" rid="T4">4</xref> indicates that all four tetramers contribute pore-lining and/or TM helix residues as well as cholesterol-binding (CRAC/CARC) domains to the major cavity within Hb. As shown, each heterotetramer contributes a total 29 blue-highlighted (pore-lining and TM helix) residues and 30 red-highlighted (cholesterol-binding) residues to the largest Hb cavity.</p>
<table-wrap position="float" id="T4">
<label>Table 4</label>
<caption><p><bold>Comparisons of the predicted cavity-lining residues in the T state hemoglobin heterotetramer CRAC/CARC motifs in red highlights; pore-lining regions in blue highlights</bold>.</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th valign="top" align="center" colspan="2"><bold>Hemoglobin &#x003B1; Chains 1GZX (141 residues in length)</bold></th>
<th valign="top" align="center" colspan="2"><bold>Hemoglobin &#x003B2; Chains 1GZX (146 residues in length)</bold></th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="center">1</td>
<td valign="top" align="center">1</td>
<td valign="top" align="center">4</td>
<td valign="top" align="center">14</td>
</tr>
<tr>
<td valign="top" align="center">10</td>
<td valign="top" align="center">35</td>
<td valign="top" align="center">20</td>
<td valign="top" align="center">16</td>
</tr>
<tr>
<td valign="top" align="center">13</td>
<td valign="top" align="center">36</td>
<td valign="top" align="center">24</td>
<td valign="top" align="center">17</td>
</tr>
<tr>
<td valign="top" align="center">36</td>
<td valign="top" align="center">37</td>
<td valign="top" align="center">25</td>
<td valign="top" align="center">18</td>
</tr>
<tr>
<td valign="top" align="center">37</td>
<td valign="top" align="center">38</td>
<td valign="top" align="center">28</td>
<td valign="top" align="center">19</td>
</tr>
<tr>
<td valign="top" align="center">77</td>
<td valign="top" align="center">43</td>
<td valign="top" align="center">29</td>
<td valign="top" align="center">23</td>
</tr>
<tr>
<td valign="top" align="center" style="color:#ed1c24">93</td>
<td valign="top" align="center">86</td>
<td valign="top" align="center" style="color:#ed1c24">32</td>
<td valign="top" align="center">24</td>
</tr>
<tr>
<td valign="top" align="center" style="color:#ed1c24">94</td>
<td valign="top" align="center" style="color:#ed1c24">92</td>
<td valign="top" align="center" style="color:#ed1c24">33</td>
<td valign="top" align="center">27</td>
</tr>
<tr>
<td valign="top" align="center" style="color:#ed1c24">95</td>
<td valign="top" align="center" style="color:#ed1c24">93</td>
<td valign="top" align="center" style="color:#ed1c24">35</td>
<td valign="top" align="center">50</td>
</tr>
<tr>
<td valign="top" align="center" style="color:#ed1c24">96</td>
<td valign="top" align="center" style="color:#ed1c24">94</td>
<td valign="top" align="center" style="color:#ed1c24">36</td>
<td valign="top" align="center">52</td>
</tr>
<tr>
<td valign="top" align="center" style="color:#ed1c24">99</td>
<td valign="top" align="center" style="color:#ed1c24">95</td>
<td valign="top" align="center" style="color:#ed1c24">37</td>
<td valign="top" align="center">67</td>
</tr>
<tr>
<td valign="top" align="center" style="color:#ed1c24">100</td>
<td valign="top" align="center" style="color:#ed1c24">97</td>
<td valign="top" align="center" style="color:#ed1c24">39</td>
<td valign="top" align="center">70</td>
</tr>
<tr>
<td valign="top" align="center">102</td>
<td valign="top" align="center" style="color:#ed1c24">98</td>
<td valign="top" align="center" style="color:#ed1c24">41</td>
<td valign="top" align="center">76</td>
</tr>
<tr>
<td valign="top" align="center">103</td>
<td valign="top" align="center" style="color:#ed1c24">99</td>
<td valign="top" align="center" style="color:#ed1c24">43</td>
<td valign="top" align="center" style="color:#48b3e6">114</td>
</tr>
<tr>
<td valign="top" align="center" style="color:#48b3e6">106</td>
<td valign="top" align="center" style="color:#ed1c24">101</td>
<td valign="top" align="center">54</td>
<td valign="top" align="center" style="color:#48b3e6">116</td>
</tr>
<tr>
<td valign="top" align="center" style="color:#48b3e6">107</td>
<td valign="top" align="center">102</td>
<td valign="top" align="center">57</td>
<td valign="top" align="center" style="color:#48b3e6">117</td>
</tr>
<tr>
<td valign="top" align="center" style="color:#48b3e6">110</td>
<td valign="top" align="center" style="color:#48b3e6">106</td>
<td valign="top" align="center">58</td>
<td valign="top" align="center" style="color:#48b3e6">118</td>
</tr>
<tr>
<td valign="top" align="center" style="color:#48b3e6">114</td>
<td valign="top" align="center" style="color:#48b3e6">107</td>
<td valign="top" align="center">63</td>
<td valign="top" align="center" style="color:#ed1c24">121</td>
</tr>
<tr>
<td valign="top" align="center" style="color:#48b3e6">115</td>
<td valign="top" align="center" style="color:#48b3e6">110</td>
<td valign="top" align="center">101</td>
<td valign="top" align="center" style="color:#ed1c24">122</td>
</tr>
<tr>
<td valign="top" align="center" style="color:#48b3e6">117</td>
<td valign="top" align="center" style="color:#48b3e6">113</td>
<td valign="top" align="center">103</td>
<td valign="top" align="center" style="color:#ed1c24">125</td>
</tr>
<tr>
<td valign="top" align="center" style="color:#48b3e6">118</td>
<td valign="top" align="center" style="color:#48b3e6">114</td>
<td valign="top" align="center">104</td>
<td valign="top" align="center" style="color:#ed1c24">126</td>
</tr>
<tr>
<td valign="top" align="center" style="color:#48b3e6">119</td>
<td valign="top" align="center" style="color:#48b3e6">116</td>
<td valign="top" align="center" style="color:#48b3e6">106</td>
<td valign="top" align="center" style="color:#ed1c24">129</td>
</tr>
<tr>
<td valign="top" align="center">121</td>
<td valign="top" align="center" style="color:#48b3e6">117</td>
<td valign="top" align="center" style="color:#48b3e6">107</td>
<td valign="top" align="center" style="color:#ed1c24">130</td>
</tr>
<tr>
<td valign="top" align="center">122</td>
<td valign="top" align="center" style="color:#48b3e6">118</td>
<td valign="top" align="center" style="color:#48b3e6">108</td>
<td valign="top" align="center">145</td>
</tr>
<tr>
<td valign="top" align="center">123</td>
<td valign="top" align="center" style="color:#48b3e6">120</td>
<td valign="top" align="center" style="color:#48b3e6">111</td>
<td valign="top" align="center">148</td>
</tr>
<tr>
<td valign="top" align="center">125</td>
<td valign="top" align="center">121</td>
<td valign="top" align="center" style="color:#48b3e6">112</td>
<td/>
</tr>
<tr>
<td valign="top" align="center">126</td>
<td valign="top" align="center">122</td>
<td valign="top" align="center" style="color:#48b3e6">113</td>
<td/>
</tr>
<tr>
<td valign="top" align="center">128</td>
<td valign="top" align="center">124</td>
<td valign="top" align="center" style="color:#48b3e6">114</td>
<td/>
</tr>
<tr>
<td valign="top" align="center">129</td>
<td valign="top" align="center">125</td>
<td valign="top" align="center" style="color:#48b3e6">115</td>
<td/>
</tr>
<tr>
<td valign="top" align="center">130</td>
<td valign="top" align="center">129</td>
<td valign="top" align="center" style="color:#48b3e6">117</td>
<td/>
</tr>
<tr>
<td valign="top" align="center">133</td>
<td valign="top" align="center">132</td>
<td valign="top" align="center" style="color:#48b3e6">118</td>
<td/>
</tr>
<tr>
<td valign="top" align="center">134</td>
<td valign="top" align="center">133</td>
<td valign="top" align="center" style="color:#48b3e6">119</td>
<td/>
</tr>
<tr>
<td valign="top" align="center">137</td>
<td valign="top" align="center">134</td>
<td valign="top" align="center" style="color:#ed1c24">120</td>
<td/>
</tr>
<tr>
<td valign="top" align="center">138</td>
<td valign="top" align="center">135</td>
<td valign="top" align="center" style="color:#ed1c24">129</td>
<td/>
</tr>
<tr>
<td valign="top" align="center">140</td>
<td valign="top" align="center">139</td>
<td valign="top" align="center" style="color:#ed1c24">133</td>
<td/>
</tr>
<tr>
<td valign="top" align="center">141</td>
<td valign="top" align="center">253</td>
<td valign="top" align="center">134</td>
<td/>
</tr>
<tr>
<td/>
<td valign="top" align="center">254</td>
<td valign="top" align="center">135</td>
<td/>
</tr>
<tr>
<td/>
<td/>
<td valign="top" align="center">139</td>
<td/>
</tr>
<tr>
<td/>
<td/>
<td valign="top" align="center">141</td>
<td/>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
</sec>
<sec sec-type="discussion" id="s4">
<title>Discussion</title>
<p>Our findings indicate that cytoglobin (Cygb), neuroglobin (Ngb), myoglobin (Mb), and hemoglobin subunit &#x003B2; (Hbb) each contain one pore-lining channel-forming amino acid sequence in the C-terminal region as well as one or more internal cavities. In contrast, Hb subunit &#x003B1; (Hba) contains one transmembrane (TM) helix in the C-terminal region compared to the pore-lining structure found in the other 4 globins. The pore-lining regions, TM helices, caveolin-binding motifs and cholesterol-binding (CRAC/CARC) motifs in <italic>H. sapiens</italic> globins and &#x0201C;band 3&#x0201D; Anion Exchange Protein 3 are summarized in Table <xref ref-type="table" rid="T5">5</xref>. The TM helix of Hba may serve as a membrane anchor for the Hb tetramer, accounting for the observed Ha binding to &#x0201C;band 3&#x0201D; in the erythrocyte membrane (e.g., Chu et al., <xref ref-type="bibr" rid="B14">2008</xref>). Residues in the pore-lining regions of Cybd, Ngb, Mb, and Hbb also line the cavities (Table <xref ref-type="table" rid="T4">4</xref>), indicating that the pore-lining regions of all 4 globins contribute to their respective cavities. Similarly, as evidenced by CRAC/CARC motif sequences highlighted in red in Table <xref ref-type="table" rid="T2">2</xref>, each globin contains bound cholesterol molecules extending into the cavity. It is important to note a possibility of &#x0201C;false positive&#x0201D; results. Many proteins were shown to have multiple CRAC/CARC motifs but have not been confirmed as actual cholesterol binding domains. A variety of ion channels, including members of all major ion channel families, have been shown to be regulated both by membrane cholesterol levels and by cholesterol partitioning into cholesterol-rich membrane domains (reviewed in Levitan and Barrantes, <xref ref-type="bibr" rid="B35">2012</xref>; Levitan et al., <xref ref-type="bibr" rid="B36">2014</xref>). At least three mechanisms for cholesterol action have been proposed by Levitan et al. (<xref ref-type="bibr" rid="B36">2014</xref>): (1) specific interactions between cholesterol and channel protein, (2) cholesterol- induced changes in the physical properties of the membrane bilayer, and (3) cholesterol maintenance of scaffolds for protein-protein interactions.</p>
<table-wrap position="float" id="T5">
<label>Table 5</label>
<caption><p><bold>Comparison of Pore-Lining regions, Caveolin-Binding Motifs and Cholesterol Binding (CRAC/CARC) Motifs in <italic><bold>Homo sapiens</bold></italic> neuroglobin, myoglobin, hemoglobin subunit &#x003B1;, and hemoglobin membrane binding sites (Anion Exchange Protein Band 3)</bold>.</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th valign="top" align="left"><bold>Protein</bold></th>
<th valign="top" align="center"><bold>Length (amino acids)</bold></th>
<th valign="top" align="left"><bold>Pore-Lining Region</bold></th>
<th valign="top" align="left"><bold>Caveolin Binding Motifs</bold></th>
<th valign="top" align="left"><bold>Cholesterol Binding (CRAC/CARC) Motifs</bold></th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">Cytoglobin</td>
<td valign="top" align="center">190</td>
<td valign="top" align="left"><sup>125</sup>K &#x02013; A<sup>140</sup></td>
<td valign="top" align="left">N.D.</td>
<td valign="top" align="left"><sup>33</sup>R &#x02013; V<sup>41</sup>, <sup>119</sup>V &#x02013; K<sup>125</sup></td>
</tr>
<tr>
<td valign="top" align="left">&#x00023;Q8WWM9</td>
<td/>
<td/>
<td/>
<td valign="top" align="left"><sup>155</sup>R &#x02013; V<sup>162</sup></td>
</tr>
<tr>
<td valign="top" align="left">Neuroglobin</td>
<td valign="top" align="center">151</td>
<td valign="top" align="left"><sup>133</sup>W &#x02013; W<sup>148</sup></td>
<td valign="top" align="left"><sup>42</sup>F &#x02013; F<sup>49</sup></td>
<td valign="top" align="left"><sup>30</sup>R &#x02013; L<sup>34</sup>, <sup>38</sup>L &#x02013; R<sup>37</sup></td>
</tr>
<tr>
<td valign="top" align="left">&#x00023;Q9NPG2</td>
<td/>
<td/>
<td/>
<td valign="top" align="left"><sup>85</sup>L &#x02013; R<sup>94</sup>, <sup>152</sup>K &#x02013; V<sup>109</sup></td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td/>
<td valign="top" align="left"><sup>113</sup>L &#x02013; K<sup>119</sup></td>
</tr>
<tr>
<td valign="top" align="left">Myoglobin</td>
<td valign="top" align="center">154</td>
<td valign="top" align="left"><sup>105</sup>L &#x02013; H<sup>120</sup></td>
<td valign="top" align="left">N.D.</td>
<td valign="top" align="left"><sup>43</sup>K &#x02013; L<sup>50</sup></td>
</tr>
<tr>
<td valign="top" align="left">&#x00023;P02144</td>
<td/>
<td/>
<td/>
<td valign="top" align="left"><sup>140</sup>K &#x02013; l<sup>150</sup></td>
</tr>
<tr>
<td valign="top" align="left">Hemoglobin Subunit &#x003B1;</td>
<td valign="top" align="center">142</td>
<td valign="top" align="left"><sup>106</sup>I &#x02013; K<sup>121</sup> (TM Helix)</td>
<td valign="top" align="left">N.D.</td>
<td valign="top" align="left"><sup>41</sup>K &#x02013; L<sup>49</sup></td>
</tr>
<tr>
<td valign="top" align="left">&#x00023;P69905</td>
<td/>
<td/>
<td/>
<td valign="top" align="left"><sup>92</sup>R &#x02013; K<sup>100</sup></td>
</tr>
<tr>
<td valign="top" align="left">Hemoglobin Subunit &#x003B2;</td>
<td valign="top" align="center">147</td>
<td valign="top" align="left"><sup>105</sup>L &#x02013; K<sup>121</sup></td>
<td valign="top" align="left"><sup>36</sup>Y &#x02013; F<sup>43</sup></td>
<td valign="top" align="left"><sup>41</sup>R &#x02013; L<sup>49</sup></td>
</tr>
<tr>
<td valign="top" align="left">&#x00023;P68871</td>
<td/>
<td/>
<td/>
<td valign="top" align="left"><sup>66</sup>K &#x02013; L<sup>76</sup></td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td/>
<td valign="top" align="left"><sup>83</sup>K &#x02013; L<sup>92</sup></td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td/>
<td valign="top" align="left"><sup>121</sup>K &#x02013; V<sup>127</sup></td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td/>
<td valign="top" align="left"><sup>127</sup>V &#x02013; K<sup>133</sup></td>
</tr>
<tr>
<td valign="top" align="left">Band 3</td>
<td valign="top" align="center">1232</td>
<td valign="top" align="left"><sup>740</sup>V &#x02013; P<sup>770</sup></td>
<td valign="top" align="left"><sup>66</sup>Y &#x02013; F<sup>73</sup></td>
<td valign="top" align="left"><sup>316</sup>K &#x02013; L<sup>324</sup>, <sup>623</sup>R &#x02013; l<sup>633</sup></td>
</tr>
<tr>
<td valign="top" align="left">Anion Exchange Protein 3</td>
<td/>
<td valign="top" align="left"><sup>827</sup>F &#x02013; K<sup>885</sup></td>
<td valign="top" align="left"><sup>774</sup>F &#x02013; F<sup>781</sup></td>
<td valign="top" align="left"><sup>692</sup>Y &#x02013; L<sup>700</sup>, <sup>789</sup>Y &#x02013; R<sup>793</sup></td>
</tr>
<tr>
<td valign="top" align="left">&#x00023;P48751</td>
<td/>
<td valign="top" align="left"><sup>928</sup>G &#x02013; Y<sup>950</sup></td>
<td valign="top" align="left"><sup>822</sup>F &#x02013; F<sup>829</sup></td>
<td valign="top" align="left"><sup>833</sup>L &#x02013; K<sup>842</sup>, <sup>967</sup>K &#x02013; L<sup>975</sup></td>
</tr>
<tr>
<td/>
<td/>
<td valign="top" align="left"><sup>1027</sup>D &#x02013; A<sup>1048</sup></td>
<td valign="top" align="left"><sup>955</sup>F &#x02013; F<sup>913</sup></td>
<td valign="top" align="left"><sup>979</sup>R &#x02013; V<sup>986</sup>, <sup>1020</sup>K &#x02013; L<sup>1030</sup></td>
</tr>
<tr>
<td/>
<td/>
<td valign="top" align="left"><sup>1107</sup>L &#x02013; L<sup>1122</sup></td>
<td/>
<td valign="top" align="left"><sup>1154</sup>R &#x02013; L<sup>1163</sup>, <sup>1198</sup>R &#x02013; l<sup>1205</sup></td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<p><italic>N.D.: none detected</italic>.</p>
</table-wrap-foot>
</table-wrap>
<p>The cavity dimensions shown for the 4 globins in Figure <xref ref-type="fig" rid="F3">3</xref> represent those of the lipid-free crystalline state and not those seen under physiological conditions. Cholesterol <italic>in vivo</italic> may serve to control cavity and/or pore/channel diameters. It is a major constituent of the plasma membrane of the eukaryotic cells essential for maintenance of membrane fluidity, thickness and dynamics, and for the compartmentalization of the lipid domains that constitute scaffolds for multiple signaling platforms (reviewed in Lingwood et al., <xref ref-type="bibr" rid="B38">2009</xref>; Levitan et al., <xref ref-type="bibr" rid="B36">2014</xref>). One of the most important known effects of cholesterol on lipid membranes is its cholesterol condensing effect. The surface area of a cholesterol-containing lipid bilayer is less than the sum of areas of the individual components (reviewed in Alwarawrah et al., <xref ref-type="bibr" rid="B2">2010</xref>). Alwarawrah et al. (<xref ref-type="bibr" rid="B2">2010</xref>) have shown that the total area of phosphatidylcholine/cholesterol is primarily determined by the molecular packing in the cholesterol sterol ring region. Analysis of the area per molecule takes into account the cholesterol tilt angle and the probable incompressibility of cholesterol sterol rings. As noted by Fantini and Barrantes (<xref ref-type="bibr" rid="B22">2013</xref>), cholesterol is an asymmetric molecule displaying both a planar &#x003B1; face and a rough &#x003B2; face. These structural features introduce a number of possible interactions between cholesterol and membrane lipids and proteins.</p>
<p>Cholesterol metabolism/turnover may also play a role. For example, in the adrenal and gonad, the steroidogenic acute regulatory protein (StAR) facilitates movement of cholesterol from outer to inner mitochondrial membrane where it is converted to pregnenolone (Clark and Stocco, <xref ref-type="bibr" rid="B15">1996</xref>; Miller and Strauss, <xref ref-type="bibr" rid="B44">1999</xref>). Our studies (Morrill et al., <xref ref-type="bibr" rid="B46">2014</xref>) have shown that subunits of the terminal enzyme in the human mitochondrial electron transfer chain (cytochrome c oxidase) contain both cholesterol (CRAC/CARC) binding motifs and leucine-rich repeats (LRRs), the latter common to plant steroid receptors (Dolan et al., <xref ref-type="bibr" rid="B20">2007</xref>). Since plant steroids such as ouabain have also been identified in humans (Blaustein, <xref ref-type="bibr" rid="B7">2014</xref>), the presence of steroid regulatory sites (LRRs) within the cytochrome c oxidase complex (reviewed in Morrill et al., <xref ref-type="bibr" rid="B46">2014</xref>) may reflect a unique StAR protein-LRR response system in vertebrates. This is consistent with the subsequent experiments by Rosenhouse-Dantsker et al. (<xref ref-type="bibr" rid="B56">2013</xref>) that indicate cholesterol binding and transfer activities are distinct from the ability to induce steroidogenesis. Rosenhouse-Dantsker et al. (<xref ref-type="bibr" rid="B56">2013</xref>) have further identified two putative cholesterol-binding regions in inwardly rectifying (Kir) channels that suggest the existence of a novel cholesterol binding motif (Rosenhouse-Dantsker et al., <xref ref-type="bibr" rid="B56">2013</xref>). Changes in erythrocyte membrane cholesterol have been shown to parallel changes in membrane surface area, as calculated from changes in osmotic fragility, with a 0.22% variation in surface area per 1.0% variation in cholesterol content (Cooper et al., <xref ref-type="bibr" rid="B16">1975</xref>).</p>
<p>Cholesterol-dependent variations in surface area would, in turn, affect both channel formation and function. The introduction of cholesterol via both CRAC/CARC (cholesterol binding) motifs and caveolin binding domains (Figure <xref ref-type="fig" rid="F5">5</xref>) could align the cavities and facilitate cross-membrane penetration of small uncharged molecules.</p>
<p>Cholesterol is also required to maintain the signaling capacity of lipid rafts (see Simons and Toomre, <xref ref-type="bibr" rid="B63">2000</xref>; Fielding and Fielding, <xref ref-type="bibr" rid="B24">2004</xref>; Grouleff et al., <xref ref-type="bibr" rid="B26">2015</xref>). Sengupta has shown (<xref ref-type="bibr" rid="B59">2012</xref>) that cholesterol modulates the depth as well as the orientation of caveolin-1 binding to membranes and that cholesterol stabilizes the more open conformations of caveolin-1. Sengupta speculates (<xref ref-type="bibr" rid="B59">2012</xref>) that the binding modes and open conformations could be responsible for inducing morphological changes in the bilayer. Both cavity formation and ligand movement within the various globins may thus be regulated by cholesterol. Pulsed laser studies by Tomita et al. (<xref ref-type="bibr" rid="B66">2009</xref>) have identified 3 cavities that play specific roles in controlling ligand migration and binding in myoglobin. Tomita et al. (<xref ref-type="bibr" rid="B66">2009</xref>) predict that the migration of the CO molecule into any cavity induces structural changes of the amino acid residues around each cavity, which results in the expansion of the cavity with a &#x0201C;breathing&#x0201D; motion. This sequential motion of the ligand and the cavity suggests a &#x0201C;self-opening mechanism of the ligand migration channel by induced fit&#x0201D; (Tomita et al. (<xref ref-type="bibr" rid="B66">2009</xref>). In addition, studies by Savino et al. (<xref ref-type="bibr" rid="B58">2009</xref>) have mapped a constellation of sites hosting up to 6 xenon atoms sites in human recombinant using Hba and Mb. The pattern of internal cavities accessibility and affinity for xenon suggest a different role for ligand migration in Hb compared to Mb.</p>
</sec>
<sec sec-type="conclusions" id="s5">
<title>Conclusions</title>
<p>Computational analysis of protein structure indicates that cytoglobin (Cygb), neuroglobin (Ngb), myoglobin (Mb), and hemoglobin subunit &#x003B2; (Hbb) each contain one pore-lining channel-forming amino acid sequence in the C-terminal region as well as one or more internal cavities. The findings described both here and elsewhere suggest that changes in ligand migration may in large part reflect changes in cholesterol-rich microdomains that occur in living cells. Cholesterol appears to be involved in a variety of physiological functions in addition to regulating ion channels and membrane dynamics. Cholesterol may serve both as a steroid hormone precursor in mitochondria (Clark and Stocco, <xref ref-type="bibr" rid="B15">1996</xref>; Miller and Strauss, <xref ref-type="bibr" rid="B44">1999</xref>) as well as structural elements of ion channels and as control elements (Simons and Toomre, <xref ref-type="bibr" rid="B63">2000</xref>; Fielding and Fielding, <xref ref-type="bibr" rid="B24">2004</xref>; Grouleff et al., <xref ref-type="bibr" rid="B26">2015</xref>) in multiple response systems.</p>
</sec>
<sec id="s6">
<title>Author contributions</title>
<p>GM and AK conceived of the study and analyzed the data. GM wrote the manuscript with input from AK. The authors thank Dr. R. K. Gupta for valuable discussions. All authors read and approved the final manuscript.</p>
<sec>
<title>Conflict of interest statement</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
</sec>
</body>
<back>
<ack>
<p>This research was supported in part by National Institutes of Health Research Grant GM-57421.</p>
</ack>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Alinchenko</surname> <given-names>M. G.</given-names></name> <name><surname>Voloshin</surname> <given-names>V. P.</given-names></name> <name><surname>Medvedev</surname> <given-names>N. N.</given-names></name> <name><surname>Mezei</surname> <given-names>M.</given-names></name> <name><surname>Partay</surname> <given-names>L.</given-names></name> <name><surname>Jedlovszky</surname> <given-names>P.</given-names></name></person-group> (<year>2005</year>). <article-title>Effect of cholesterol on the properties of phospholipid membranes. 4. Interatomic voids</article-title>. <source>J. Phys. Chem. B</source> <volume>109</volume>, <fpage>16490</fpage>&#x02013;<lpage>16502</lpage>. <pub-id pub-id-type="doi">10.1021/jp051832s</pub-id><pub-id pub-id-type="pmid">16853097</pub-id></citation>
</ref>
<ref id="B2">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Alwarawrah</surname> <given-names>M.</given-names></name> <name><surname>Dai</surname> <given-names>J.</given-names></name> <name><surname>Huang</surname> <given-names>J.</given-names></name></person-group> (<year>2010</year>). <article-title>A molecular view of the cholesterol condensing effect in DOPC lipid bilayers</article-title>. <source>J. Phys. Chem. B</source> <volume>114</volume>, <fpage>7516</fpage>&#x02013;<lpage>7523</lpage>. <pub-id pub-id-type="doi">10.1021/jp101415g</pub-id><pub-id pub-id-type="pmid">20469902</pub-id></citation>
</ref>
<ref id="B3">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Andrade</surname> <given-names>C. T.</given-names></name> <name><surname>Barros</surname> <given-names>L. A.</given-names></name> <name><surname>Lima</surname> <given-names>M. C.</given-names></name> <name><surname>Azeo</surname> <given-names>E. G.</given-names></name></person-group> (<year>2004</year>). <article-title>Purification and characterization of human hemoglobin: effect of the hemolysis conditions</article-title>. <source>Int. J. Biol. Macromol.</source> <volume>34</volume>, <fpage>233</fpage>&#x02013;<lpage>240</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijbiomac.2004.05.003</pub-id><pub-id pub-id-type="pmid">15374679</pub-id></citation>
</ref>
<ref id="B4">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Baier</surname> <given-names>C. J.</given-names></name> <name><surname>Fantini</surname> <given-names>J.</given-names></name> <name><surname>Barrantes</surname> <given-names>F. J.</given-names></name></person-group> (<year>2011</year>). <article-title>Disclosure of cholesterol recognition motifs in transmembrane domains of the human nicotinic acetylcholine receptor</article-title>. <source>Sci. Rep.</source> <volume>1</volume>:<fpage>69</fpage>. <pub-id pub-id-type="doi">10.1038/srep00069</pub-id><pub-id pub-id-type="pmid">22355588</pub-id></citation>
</ref>
<ref id="B5">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Banerjee</surname> <given-names>S.</given-names></name> <name><surname>Chakraborti</surname> <given-names>A. S.</given-names></name></person-group> (<year>2014</year>). <article-title>Structural alterations of hemoglobin and myoglobin by glyoxal: a comparative study</article-title>. <source>Int. J. Biol. Macromol.</source> <volume>66</volume>, <fpage>311</fpage>&#x02013;<lpage>318</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijbiomac.2014.02.034</pub-id><pub-id pub-id-type="pmid">24613676</pub-id></citation>
</ref>
<ref id="B6">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Batey</surname> <given-names>S.</given-names></name> <name><surname>Nickson</surname> <given-names>A. A.</given-names></name> <name><surname>Clark</surname> <given-names>J.</given-names></name></person-group> (<year>2008</year>). <article-title>Studying the folding of multidomain proteins</article-title>. <source>HFSP J.</source> <volume>5392</volume>, <fpage>365</fpage>&#x02013;<lpage>377</lpage>. <pub-id pub-id-type="doi">10.2976/1.2991513</pub-id><pub-id pub-id-type="pmid">19436439</pub-id></citation>
</ref>
<ref id="B7">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Blaustein</surname> <given-names>M. P.</given-names></name></person-group> (<year>2014</year>). <article-title>Why isn&#x00027;t endogenous ouabain more widely accepted?</article-title> <source>Am. J. Physiol. Heart Circ. Physiol.</source> <volume>307</volume>, <fpage>H635</fpage>&#x02013;<lpage>H639</lpage>. <pub-id pub-id-type="doi">10.1152/ajpheart.00404.2014</pub-id><pub-id pub-id-type="pmid">24993043</pub-id></citation>
</ref>
<ref id="B8">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Brunori</surname> <given-names>M.</given-names></name> <name><surname>Gibson</surname> <given-names>Q. H.</given-names></name></person-group> (<year>2001</year>). <article-title>Cavities and packing defects in the structural dynamics of myoblobin</article-title>. <source>EMBO Rep.</source> <volume>21</volume>, <fpage>674</fpage>&#x02013;<lpage>679</lpage>. <pub-id pub-id-type="doi">10.1093/embo-reports/kve159</pub-id><pub-id pub-id-type="pmid">11493595</pub-id></citation>
</ref>
<ref id="B9">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Brunori</surname> <given-names>M.</given-names></name> <name><surname>Gluffr&#x000E8;</surname> <given-names>A.</given-names></name> <name><surname>Nienhaus</surname> <given-names>K.</given-names></name> <name><surname>Nienhaus</surname> <given-names>G. U.</given-names></name> <name><surname>Scandurra</surname> <given-names>F. M.</given-names></name> <name><surname>Vallone</surname> <given-names>B.</given-names></name></person-group> (<year>2005</year>). <article-title>Neuroglobin, nitric oxide, and oxygen: functional pathways and conformational changes</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A.</source> <volume>102</volume>, <fpage>8483</fpage>&#x02013;<lpage>8488</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0408766102</pub-id><pub-id pub-id-type="pmid">15932948</pub-id></citation>
</ref>
<ref id="B10">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bryson</surname> <given-names>K.</given-names></name> <name><surname>Cozzetto</surname> <given-names>D.</given-names></name> <name><surname>Jones</surname> <given-names>D. T.</given-names></name></person-group> (<year>2007</year>). <article-title>Computer-assisted protein domain boundry prediction using DomPred server</article-title>. <source>Curr. Protein Pept. Sci.</source> <volume>8</volume>, <fpage>181</fpage>&#x02013;<lpage>188</lpage>. <pub-id pub-id-type="doi">10.2174/138920307780363415</pub-id><pub-id pub-id-type="pmid">17430199</pub-id></citation>
</ref>
<ref id="B11">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Burmeister</surname> <given-names>T.</given-names></name> <name><surname>Hankeln</surname> <given-names>T.</given-names></name></person-group> (<year>2014</year>). <article-title>Function and evolution of vertebrate globins</article-title>. <source>Acta Physiol. (Oxf)</source> <volume>211</volume>, <fpage>501</fpage>&#x02013;<lpage>514</lpage>. <pub-id pub-id-type="doi">10.1111/apha.12312</pub-id><pub-id pub-id-type="pmid">24811692</pub-id></citation>
</ref>
<ref id="B12">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cabrales</surname> <given-names>P.</given-names></name> <name><surname>Salazar V&#x000E1;zquez</surname> <given-names>M. A.</given-names></name> <name><surname>Salazar V&#x000E1;zquez</surname> <given-names>B. Y.</given-names></name> <name><surname>Rodr&#x000ED;guez-Mor&#x000E1;n</surname> <given-names>M.</given-names></name> <name><surname>Intaglietta</surname> <given-names>M.</given-names></name> <name><surname>Guerrero-Romero</surname> <given-names>F.</given-names></name></person-group> (<year>2008</year>). <article-title>Blood pressure reduction due to hemoglobin glycosylation in type 2 diabetic patients</article-title>. <source>Vasc. Health Risk Manag.</source> <volume>4</volume>, <fpage>917</fpage>&#x02013;<lpage>922</lpage>. <pub-id pub-id-type="pmid">19066010</pub-id></citation>
</ref>
<ref id="B13">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Carpenter</surname> <given-names>E. P.</given-names></name> <name><surname>Beis</surname> <given-names>K.</given-names></name> <name><surname>Cameron</surname> <given-names>A. D.</given-names></name> <name><surname>Iwata</surname> <given-names>S.</given-names></name></person-group> (<year>2008</year>). <article-title>Overcoming the challenges of membrane protein crystallography</article-title>. <source>Curr. Opin. Struct. Biol.</source> <volume>18</volume>, <fpage>581</fpage>&#x02013;<lpage>586</lpage>. <pub-id pub-id-type="doi">10.1016/j.sbi.2008.07.001</pub-id><pub-id pub-id-type="pmid">18674618</pub-id></citation>
</ref>
<ref id="B14">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chu</surname> <given-names>H.</given-names></name> <name><surname>Breite</surname> <given-names>A.</given-names></name> <name><surname>Ciraolo</surname> <given-names>P.</given-names></name> <name><surname>Franco</surname> <given-names>R. S.</given-names></name> <name><surname>Low</surname> <given-names>P. S.</given-names></name></person-group> (<year>2008</year>). <article-title>Characterization of the deoxyhemoglobin binding site on human erythrocyte band 3: implications for O2 regulation of erythrocyte properties</article-title>. <source>Blood.</source> <volume>111</volume>, <fpage>932</fpage>&#x02013;<lpage>938</lpage>. <pub-id pub-id-type="doi">10.1182/blood-2007-07-100180</pub-id><pub-id pub-id-type="pmid">17942752</pub-id></citation>
</ref>
<ref id="B15">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Clark</surname> <given-names>B. J.</given-names></name> <name><surname>Stocco</surname> <given-names>D. M.</given-names></name></person-group> (<year>1996</year>). <article-title>StAR-A tissue specific acute mediator of steroidogenesis</article-title>. <source>Trends Endocrinol. Metab.</source> <volume>7</volume>, <fpage>227</fpage>&#x02013;<lpage>233</lpage>. <pub-id pub-id-type="doi">10.1016/S1043-2760(96)00114-2</pub-id><pub-id pub-id-type="pmid">18406752</pub-id></citation>
</ref>
<ref id="B16">
<citation citation-type="book"><person-group person-group-type="author"><name><surname>Cooper</surname> <given-names>R. A.</given-names></name> <name><surname>Arner</surname> <given-names>E. C.</given-names></name> <name><surname>Wiley</surname> <given-names>J. S.</given-names></name> <name><surname>Shattil</surname> <given-names>S. J.</given-names></name></person-group> (<year>1975</year>). <article-title>Modification of red cell membrane structure by cholesterol-rich lipid dispersions. A model for the primary spur cell defect</article-title>. <source>J. Clin. Invest.</source> <volume>55</volume>, <fpage>115</fpage>&#x02013;<lpage>126</lpage>. <pub-id pub-id-type="doi">10.1172/JCI107901</pub-id><pub-id pub-id-type="pmid">162782</pub-id></citation>
</ref>
<ref id="B17">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Couet</surname> <given-names>J.</given-names></name> <name><surname>Sargiacomo</surname> <given-names>M.</given-names></name> <name><surname>Lisanti</surname> <given-names>M. P.</given-names></name></person-group> (<year>1997</year>). <article-title>Interaction of a receptor tyrosine kinase, EGF-R, with caveolins</article-title>. <source>J. Biol. Chem.</source> <volume>272</volume>, <fpage>30429</fpage>&#x02013;<lpage>30438</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.272.48.30429</pub-id><pub-id pub-id-type="pmid">9374534</pub-id></citation>
</ref>
<ref id="B18">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dill</surname> <given-names>K. A.</given-names></name> <name><surname>Ozkan</surname> <given-names>S. B.</given-names></name> <name><surname>Shell</surname> <given-names>M. S.</given-names></name> <name><surname>Weikl</surname> <given-names>T. R.</given-names></name></person-group> (<year>2008</year>). <article-title>The protein folding problem</article-title>. <source>Annu. Rev. Biophys.</source> <volume>37</volume>, <fpage>289</fpage>&#x02013;<lpage>316</lpage>. <pub-id pub-id-type="doi">10.1146/annurev.Biophys.37.092707.100001</pub-id><pub-id pub-id-type="pmid">18573083</pub-id></citation>
</ref>
<ref id="B19">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dobson</surname> <given-names>L.</given-names></name> <name><surname>Remenyl</surname> <given-names>I.</given-names></name> <name><surname>Tusnady</surname> <given-names>G. E.</given-names></name></person-group> (<year>2015</year>). <article-title>CCTOP: a Concensus Constrained TOPology prediction web server</article-title>. <source>Nucl. Acids Res.</source> <volume>43</volume>, <fpage>W408</fpage>&#x02013;<lpage>W412</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkv451</pub-id><pub-id pub-id-type="pmid">25943549</pub-id></citation>
</ref>
<ref id="B20">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dolan</surname> <given-names>J.</given-names></name> <name><surname>Walshe</surname> <given-names>K.</given-names></name> <name><surname>Alsbury</surname> <given-names>S.</given-names></name> <name><surname>Hokamp</surname> <given-names>K.</given-names></name> <name><surname>O&#x00027;Keeffe</surname> <given-names>S.</given-names></name> <name><surname>Okafuji</surname> <given-names>T.</given-names></name> <etal/></person-group>. (<year>2007</year>). <article-title>The extracellular leucine-rich repeat superfamily; a comparative survey and analysis of evolutionary relationships and expression patterns</article-title>. <source>BMC Genomics</source> <volume>8</volume>:<fpage>320</fpage>. <pub-id pub-id-type="doi">10.1186/1471-2164-8-320</pub-id><pub-id pub-id-type="pmid">17868438</pub-id></citation>
</ref>
<ref id="B21">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Drabkin</surname> <given-names>H. J.</given-names></name> <name><surname>RajBhandary</surname> <given-names>U. L.</given-names></name></person-group> (<year>1998</year>). <article-title>Initiation of protein synthesis in mammalian cells with codons other than AUG and amino acids other than methionine</article-title>. <source>Mol. Cell Biol.</source> <volume>18</volume>, <fpage>5140</fpage>&#x02013;<lpage>5147</lpage>. <pub-id pub-id-type="doi">10.1128/MCB.18.9.5140</pub-id><pub-id pub-id-type="pmid">9710598</pub-id></citation>
</ref>
<ref id="B22">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fantini</surname> <given-names>J.</given-names></name> <name><surname>Barrantes</surname> <given-names>F. J.</given-names></name></person-group> (<year>2013</year>). <article-title>How cholesterol interacts with membrane proteins: an exploration of cholesterol-binding sites including CRAC, CARC, and tilted domains</article-title>. <source>Front. Physiol.</source> <volume>4</volume>:<issue>31</issue>. <pub-id pub-id-type="doi">10.3389/fphys.2013.00031</pub-id><pub-id pub-id-type="pmid">23450735</pub-id></citation>
</ref>
<ref id="B23">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fantini</surname> <given-names>J.</given-names></name> <name><surname>Di Scala</surname> <given-names>C.</given-names></name> <name><surname>Evans</surname> <given-names>L. S.</given-names></name> <name><surname>Williamson</surname> <given-names>P. T.</given-names></name> <name><surname>Barrantes</surname> <given-names>F. J.</given-names></name></person-group> (<year>2016</year>). <article-title>A mirror code for protein-cholesterol interactions in the two leaflrts of biological membranes</article-title>. <source>Sci. Rep.</source> <volume>6</volume>:<fpage>21907</fpage>. <pub-id pub-id-type="doi">10.1038/srep21907</pub-id><pub-id pub-id-type="pmid">26915987</pub-id></citation>
</ref>
<ref id="B24">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fielding</surname> <given-names>C. J.</given-names></name> <name><surname>Fielding</surname> <given-names>P. E.</given-names></name></person-group> (<year>2004</year>). <article-title>Membrane cholesterol and the regulation of signal transduction</article-title>. <source>Biochem. Soc. Trans.</source> <volume>32</volume>, <fpage>65</fpage>&#x02013;<lpage>69</lpage>. <pub-id pub-id-type="doi">10.1042/bst0320065</pub-id><pub-id pub-id-type="pmid">14748714</pub-id></citation>
</ref>
<ref id="B25">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gilbert</surname> <given-names>R. J.</given-names></name> <name><surname>Dalla Serra</surname> <given-names>M.</given-names></name> <name><surname>Froelich</surname> <given-names>C. J.</given-names></name> <name><surname>Wallace</surname> <given-names>M. I.</given-names></name> <name><surname>Anderluh</surname> <given-names>G.</given-names></name></person-group> (<year>2014</year>). <article-title>Membrane pore formation at protein-lipid interfaces</article-title>. <source>Trends Biochem. Sci.</source> <volume>39</volume>, <fpage>510</fpage>&#x02013;<lpage>516</lpage>. <pub-id pub-id-type="doi">10.1016/j.tibs.2014.09.002</pub-id><pub-id pub-id-type="pmid">25440714</pub-id></citation>
</ref>
<ref id="B26">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Grouleff</surname> <given-names>J.</given-names></name> <name><surname>Irudayam</surname> <given-names>S. J.</given-names></name> <name><surname>Skeby</surname> <given-names>K. K.</given-names></name> <name><surname>Schi&#x000F8;tt</surname> <given-names>B.</given-names></name></person-group> (<year>2015</year>). <article-title>The influence of cholesterol on membrane protein structure, function, and dynamics studied by molecular dynamics simulations</article-title>. <source>Biochim. Biophys. Acta</source> <volume>1848</volume>, <fpage>1783</fpage>&#x02013;<lpage>1795</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbamem.2015.03.029</pub-id><pub-id pub-id-type="pmid">25839353</pub-id></citation>
</ref>
<ref id="B27">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hall</surname> <given-names>S. E.</given-names></name> <name><surname>Roberts</surname> <given-names>K.</given-names></name> <name><surname>Vaidehi</surname> <given-names>N.</given-names></name></person-group> (<year>2009</year>). <article-title>Position of helical kinks in membrane crystal structures and the accuracy of computational prediction</article-title>. <source>J. Mol. Graph. Model.</source> <volume>27</volume>, <fpage>944</fpage>&#x02013;<lpage>950</lpage>. <pub-id pub-id-type="doi">10.1016/j.jmgm.2009.02.004</pub-id><pub-id pub-id-type="pmid">19285892</pub-id></citation>
</ref>
<ref id="B28">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hardison</surname> <given-names>R. C.</given-names></name></person-group> (<year>1996</year>). <article-title>A brief history of hemoglobins: plant, animal, protest, and bacteria</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A.</source> <volume>93</volume>, <fpage>5675</fpage>&#x02013;<lpage>5679</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.93.12.5675</pub-id><pub-id pub-id-type="pmid">8650150</pub-id></citation>
</ref>
<ref id="B29">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hardison</surname> <given-names>R.</given-names></name></person-group> (<year>1998</year>). <article-title>Hemoglobins from bacteria to man: evolution of different patterns of gene expression</article-title>. <source>J. Exp. Biol.</source> <volume>201</volume>, <fpage>1099</fpage>&#x02013;<lpage>1117</lpage>. <pub-id pub-id-type="pmid">9510523</pub-id></citation>
</ref>
<ref id="B30">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Heberle</surname> <given-names>F. A.</given-names></name> <name><surname>Feigenson</surname> <given-names>G. W.</given-names></name></person-group> (<year>2011</year>). <article-title>Phase separation in lipid membranes</article-title>. <source>Cold Spring Harb. Perspect. Biol.</source> <volume>3</volume>:<fpage>a004630</fpage>. <pub-id pub-id-type="doi">10.1101/cshperspect.a004630</pub-id><pub-id pub-id-type="pmid">24642407</pub-id></citation>
</ref>
<ref id="B31">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hildebrand</surname> <given-names>P. W.</given-names></name> <name><surname>Lorenzen</surname> <given-names>S.</given-names></name> <name><surname>Goede</surname> <given-names>A.</given-names></name> <name><surname>Preissner</surname> <given-names>R.</given-names></name></person-group> (<year>2006</year>). <article-title>Analysis and prediction of helix- helix interactions in membrane channels and transporters</article-title>. <source>Proteins</source> <volume>64</volume>, <fpage>253</fpage>&#x02013;<lpage>262</lpage>. <pub-id pub-id-type="doi">10.1002/prot.20959</pub-id><pub-id pub-id-type="pmid">16555307</pub-id></citation>
</ref>
<ref id="B32">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hildebrand</surname> <given-names>P. W.</given-names></name> <name><surname>Preissner</surname> <given-names>R.</given-names></name> <name><surname>F&#x000F6;mmel</surname> <given-names>C.</given-names></name></person-group> (<year>2004</year>). <article-title>Structural features of transmembrane helices</article-title>. <source>FEBS Lett.</source> <volume>559</volume>, <fpage>145</fpage>&#x02013;<lpage>151</lpage>. <pub-id pub-id-type="doi">10.1016/S0014-5793(04)00061-4</pub-id><pub-id pub-id-type="pmid">14960323</pub-id></citation>
</ref>
<ref id="B33">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hoogewijs</surname> <given-names>D.</given-names></name> <name><surname>Geuens</surname> <given-names>E.</given-names></name> <name><surname>Dewilde</surname> <given-names>S.</given-names></name> <name><surname>Vierstraete</surname> <given-names>A.</given-names></name> <name><surname>Moens</surname> <given-names>L.</given-names></name> <name><surname>Vinogradov</surname> <given-names>S.</given-names></name> <etal/></person-group>. (<year>2007</year>). <article-title>Wide diversity in structure and expression profiles among members of the <italic>Coenorhabditis elegans</italic> globin protein family</article-title>. <source>BMC Genomics</source> <volume>8</volume>:<fpage>356</fpage>. <pub-id pub-id-type="doi">10.1186/1471-2164-8-356</pub-id><pub-id pub-id-type="pmid">17916248</pub-id></citation>
</ref>
<ref id="B34">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Laberge</surname> <given-names>M.</given-names></name> <name><surname>Yonetani</surname> <given-names>T.</given-names></name></person-group> (<year>2007</year>). <article-title>Common dynamics of globin family proteins</article-title>. <source>IUBMB Life</source> <volume>59</volume>, <fpage>528</fpage>&#x02013;<lpage>534</lpage>. <pub-id pub-id-type="doi">10.1080/15216540701222914</pub-id><pub-id pub-id-type="pmid">17701547</pub-id></citation>
</ref>
<ref id="B35">
<citation citation-type="book"><person-group person-group-type="editor"><name><surname>Levitan</surname> <given-names>I.</given-names></name> <name><surname>Barrantes</surname> <given-names>F. J.</given-names></name></person-group> (eds.). (<year>2012</year>). <source>Cholesterol Regulation of Ion Channels and Receptors</source>. <publisher-loc>New York, NY</publisher-loc>: <publisher-name>John Wiley &#x00026; Sons</publisher-name>.</citation>
</ref>
<ref id="B36">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Levitan</surname> <given-names>I.</given-names></name> <name><surname>Singh</surname> <given-names>D. K.</given-names></name> <name><surname>Rosenhouse-Dantsker</surname> <given-names>A.</given-names></name></person-group> (<year>2014</year>). <article-title>Cholesterol binding to ion channels</article-title>. <source>Front. Physiol.</source> <volume>5</volume>:<issue>65</issue>. <pub-id pub-id-type="doi">10.3389/fphys.2014.00065</pub-id><pub-id pub-id-type="pmid">24616704</pub-id></citation>
</ref>
<ref id="B37">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Li</surname> <given-names>H.</given-names></name> <name><surname>Papadopoulos</surname> <given-names>V.</given-names></name></person-group> (<year>1998</year>). <article-title>Peripheral-type benzodiazepine receptor function in cholesterol transport. Identification of a putative cholesterol recognition/interaction amino acid sequence and consensus pattern</article-title>. <source>Endocrinology</source> <volume>139</volume>, <fpage>4991</fpage>&#x02013;<lpage>4997</lpage>. <pub-id pub-id-type="pmid">9832438</pub-id></citation>
</ref>
<ref id="B38">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lingwood</surname> <given-names>D.</given-names></name> <name><surname>Kaiser</surname> <given-names>H. J.</given-names></name> <name><surname>Levental</surname> <given-names>I.</given-names></name> <name><surname>Simons</surname> <given-names>K.</given-names></name></person-group> (<year>2009</year>). <article-title>Lipid rafts as functional heterogeneity in cell membranes</article-title>. <source>Biochem. Soc. Trans.</source> <volume>37</volume>, <fpage>955</fpage>&#x02013;<lpage>960</lpage>. <pub-id pub-id-type="doi">10.1042/BST0370955</pub-id><pub-id pub-id-type="pmid">19754431</pub-id></citation>
</ref>
<ref id="B39">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Listowski</surname> <given-names>M. A.</given-names></name> <name><surname>Leluk</surname> <given-names>J.</given-names></name> <name><surname>Kraszewski</surname> <given-names>S.</given-names></name> <name><surname>Sikorski</surname> <given-names>A. F.</given-names></name></person-group> (<year>2015</year>). <article-title>Cholesterol interaction with the MAGUK protein family member, MPP1, via CRAC and CRAC-like motifs: An <italic>in silico</italic> docking analysis</article-title>. <source>PLOS ONE</source> <volume>10</volume>:<fpage>e0133141</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0133141</pub-id><pub-id pub-id-type="pmid">26186446</pub-id></citation>
</ref>
<ref id="B40">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname> <given-names>P.</given-names></name> <name><surname>Rudick</surname> <given-names>M.</given-names></name> <name><surname>Anderson</surname> <given-names>R. G. W.</given-names></name></person-group> (<year>2002</year>). <article-title>Multiple functions of caveolin-1</article-title>. <source>J. Biol. Chem.</source> <volume>277</volume>, <fpage>41295</fpage>&#x02013;<lpage>41298</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.R200020200</pub-id><pub-id pub-id-type="pmid">12189159</pub-id></citation>
</ref>
<ref id="B41">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mammen</surname> <given-names>P. P.</given-names></name> <name><surname>Shelton</surname> <given-names>J. M.</given-names></name> <name><surname>Goetsch</surname> <given-names>S. C.</given-names></name> <name><surname>Williams</surname> <given-names>S. C.</given-names></name> <name><surname>Richardson</surname> <given-names>J. A.</given-names></name> <name><surname>Garry</surname> <given-names>M. G.</given-names></name> <etal/></person-group>. (<year>2002</year>). <article-title>Neuroglobin, a novel member of the globin family, is expressed in focal regions of the brain</article-title>. <source>J. Histochem. Cytochem.</source> <volume>50</volume>, <fpage>1591</fpage>&#x02013;<lpage>1598</lpage>. <pub-id pub-id-type="doi">10.1177/002215540205001203</pub-id><pub-id pub-id-type="pmid">12486081</pub-id></citation>
</ref>
<ref id="B42">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Marsden</surname> <given-names>R. L.</given-names></name> <name><surname>McGuffin</surname> <given-names>L. J.</given-names></name> <name><surname>Jones</surname> <given-names>D. T.</given-names></name></person-group> (<year>2002</year>). <article-title>Rapid protein domain assignment from amino acid sequence using predicted structure</article-title>. <source>Protein Sci.</source> <volume>11</volume>, <fpage>2814</fpage>&#x02013;<lpage>2824</lpage>. <pub-id pub-id-type="doi">10.1110/ps.0209902</pub-id><pub-id pub-id-type="pmid">12441380</pub-id></citation>
</ref>
<ref id="B43">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Meruelo</surname> <given-names>A. D.</given-names></name> <name><surname>Samish</surname> <given-names>I.</given-names></name> <name><surname>Bowie</surname> <given-names>J. U.</given-names></name></person-group> (<year>2011</year>). <article-title>TMkink: a method to predict transmembrane helix kinks</article-title>. <source>Protein Sci.</source> <volume>20</volume>, <fpage>1256</fpage>&#x02013;<lpage>1264</lpage>. <pub-id pub-id-type="doi">10.1002/pro.653</pub-id><pub-id pub-id-type="pmid">21563225</pub-id></citation>
</ref>
<ref id="B44">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Miller</surname> <given-names>W. L.</given-names></name> <name><surname>Strauss</surname> <given-names>J. F.</given-names> <suffix>III.</suffix></name></person-group> (<year>1999</year>). <article-title>Molecular pathology and mechanism of action of the steroidogenic acute regulatory protein, StAR. <italic>J. Steroid Biochem. Mol</italic></article-title>. <source>Biol.</source> <volume>69</volume>, <fpage>131</fpage>&#x02013;<lpage>141</lpage>. <pub-id pub-id-type="doi">10.1016/S0960-0760(98)00153-8</pub-id></citation>
</ref>
<ref id="B45">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Moremen</surname> <given-names>K. W.</given-names></name> <name><surname>Tiemeyer</surname> <given-names>M.</given-names></name> <name><surname>Nairn</surname> <given-names>A. V.</given-names></name></person-group> (<year>2012</year>). <article-title>Vertebrate protein glycosylation: diversity, synthesis and function</article-title>. <source>Nat. Rev. Mol. Cell Biol.</source> <volume>13</volume>, <fpage>448</fpage>&#x02013;<lpage>462</lpage>. <pub-id pub-id-type="doi">10.1038/nrm3383</pub-id><pub-id pub-id-type="pmid">22722607</pub-id></citation>
</ref>
<ref id="B46">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Morrill</surname> <given-names>G. A.</given-names></name> <name><surname>Kostellow</surname> <given-names>A. B.</given-names></name> <name><surname>Gupta</surname> <given-names>R. K.</given-names></name></person-group> (<year>2014</year>). <article-title>The pore-lining regions of cytochrome c oxidases: a computational analysis of caveolin, cholesterol and transmembrane helix contributions to proton movement</article-title>. <source>Biochim. Biophys. Acta</source> <volume>1838</volume>, <fpage>2838</fpage>&#x02013;<lpage>2851</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbamem.2014.07.011</pub-id><pub-id pub-id-type="pmid">25037006</pub-id></citation>
</ref>
<ref id="B47">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nugent</surname> <given-names>T.</given-names></name> <name><surname>Jones</surname> <given-names>D. T.</given-names></name></person-group> (<year>2012</year>). <article-title>Detecting pore-lining regions in transmembrane protein sequences</article-title>. <source>BMC Bioinfomatics</source> <volume>13</volume>:<fpage>169</fpage>. <pub-id pub-id-type="doi">10.1186/1471-2105-13-169</pub-id><pub-id pub-id-type="pmid">22805427</pub-id></citation>
</ref>
<ref id="B48">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nugent</surname> <given-names>T.</given-names></name> <name><surname>Ward</surname> <given-names>S.</given-names></name> <name><surname>Jones</surname> <given-names>D. T.</given-names></name></person-group> (<year>2011</year>). <article-title>The MEMPACK alpha-helical transmembrane protein structure prediction server</article-title>. <source>Bioinfomatics</source> <volume>27</volume>, <fpage>1438</fpage>&#x02013;<lpage>1439</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btr096</pub-id><pub-id pub-id-type="pmid">21349872</pub-id></citation>
</ref>
<ref id="B49">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Olson</surname> <given-names>J. S.</given-names></name> <name><surname>Soman</surname> <given-names>J.</given-names></name> <name><surname>Phillips</surname> <given-names>G. N.</given-names> <suffix>Jr.</suffix></name></person-group> (<year>2007</year>). <article-title>Ligand pathways in myoglobin: a review of trp cavity mutations</article-title>. <source>IUMB Life</source> <volume>59</volume>, <fpage>552</fpage>&#x02013;<lpage>562</lpage>. <pub-id pub-id-type="doi">10.1080/15216540701230495</pub-id><pub-id pub-id-type="pmid">17701550</pub-id></citation>
</ref>
<ref id="B50">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pang</surname> <given-names>C. N.</given-names></name> <name><surname>Lin</surname> <given-names>K.</given-names></name> <name><surname>Wouters</surname> <given-names>M. A.</given-names></name> <name><surname>Heringa</surname> <given-names>J.</given-names></name> <name><surname>George</surname> <given-names>R. A.</given-names></name></person-group> (<year>2008</year>). <article-title>Identifying foldable regions in protein sequence from the hydrophobic signal</article-title>. <source>Nucleic Acids Res.</source> <volume>36</volume>, <fpage>578</fpage>&#x02013;<lpage>588</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkm1070</pub-id><pub-id pub-id-type="pmid">18056079</pub-id></citation>
</ref>
<ref id="B51">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Paramo</surname> <given-names>T.</given-names></name> <name><surname>East</surname> <given-names>A.</given-names></name> <name><surname>Garz&#x000F3;n</surname> <given-names>D.</given-names></name> <name><surname>Ulmschneider</surname> <given-names>M. B.</given-names></name> <name><surname>Bond</surname> <given-names>P. J.</given-names></name></person-group> (<year>2014</year>). <article-title>Efficient characterization of Protein cavities within molecular simulation trajectories:trj_cavity</article-title>. <source>J. Chem. Theory Comput.</source> <volume>10</volume>, <fpage>2151</fpage>&#x02013;<lpage>2164</lpage>. <pub-id pub-id-type="doi">10.1021/ct401098b</pub-id><pub-id pub-id-type="pmid">26580540</pub-id></citation>
</ref>
<ref id="B52">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pellegrini-Calace</surname> <given-names>M.</given-names></name> <name><surname>Maiwald</surname> <given-names>T.</given-names></name> <name><surname>Thorton</surname> <given-names>J. M.</given-names></name></person-group> (<year>2009</year>). <article-title>A novel tool for the identification and characterization of channels in transmembrane proteins from their three-dimensional structure</article-title>. <source>PLoS Comput. Biol.</source> <volume>5</volume>:<fpage>e1000440</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pcbi.1000440</pub-id><pub-id pub-id-type="pmid">19609355</pub-id></citation>
</ref>
<ref id="B53">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pesce</surname> <given-names>A.</given-names></name> <name><surname>Bolognesi</surname> <given-names>M.</given-names></name> <name><surname>Bocedi</surname> <given-names>A.</given-names></name> <name><surname>Ascenzi</surname> <given-names>P.</given-names></name> <name><surname>Dewilde</surname> <given-names>S.</given-names></name> <name><surname>Moens</surname> <given-names>L.</given-names></name> <etal/></person-group>. (<year>2002</year>). <article-title>Neuroglobin and cytoglobin. Fresh blood for the vertebrate globin family</article-title>. <source>EMBO Rep.</source> <volume>3</volume>, <fpage>1146</fpage>&#x02013;<lpage>1151</lpage>. <pub-id pub-id-type="doi">10.1093/embo-reports/kvf248</pub-id><pub-id pub-id-type="pmid">12475928</pub-id></citation>
</ref>
<ref id="B54">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Richter</surname> <given-names>F.</given-names></name> <name><surname>Meurers</surname> <given-names>B. H.</given-names></name> <name><surname>Zhu</surname> <given-names>C.</given-names></name> <name><surname>Medvedeva</surname> <given-names>V. P.</given-names></name> <name><surname>Chesselet</surname> <given-names>M. F.</given-names></name></person-group> (<year>2009</year>). <article-title>Neurons express hemoglobin &#x003B1;- and &#x003B2;-chains in rat and human brains</article-title>. <source>J. Comp. Neurol.</source> <volume>515</volume>, <fpage>538</fpage>&#x02013;<lpage>547</lpage>. <pub-id pub-id-type="doi">10.1002/cne.22062</pub-id><pub-id pub-id-type="pmid">19479992</pub-id></citation>
</ref>
<ref id="B55">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Roche</surname> <given-names>C. J.</given-names></name> <name><surname>Cassera</surname> <given-names>M. B.</given-names></name> <name><surname>Dantsker</surname> <given-names>D.</given-names></name> <name><surname>Hirsch</surname> <given-names>R. E.</given-names></name> <name><surname>Friedman</surname> <given-names>J. M.</given-names></name></person-group> (<year>2013</year>). <article-title>Generating S- Nitrosothiols from hemoglobin mechanisms, conformational dependence, and physiological relevance</article-title>. <source>J. Biol. Chem.</source> <volume>288</volume>, <fpage>22408</fpage>&#x02013;<lpage>22425</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M113.482679</pub-id><pub-id pub-id-type="pmid">23775069</pub-id></citation>
</ref>
<ref id="B56">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rosenhouse-Dantsker</surname> <given-names>A.</given-names></name> <name><surname>Noskov</surname> <given-names>S.</given-names></name> <name><surname>Durdagi</surname> <given-names>S.</given-names></name> <name><surname>Logothetis</surname> <given-names>D. E.</given-names></name> <name><surname>Levitan</surname> <given-names>I.</given-names></name></person-group> (<year>2013</year>). <article-title>Identification of novel cholesterol-binding regions in Kir2 channels</article-title>. <source>J. Biol. Chem.</source> <volume>288</volume>, <fpage>31154</fpage>&#x02013;<lpage>31164</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M113.496117</pub-id><pub-id pub-id-type="pmid">24019518</pub-id></citation>
</ref>
<ref id="B57">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Salter</surname> <given-names>M. D.</given-names></name> <name><surname>Blouin</surname> <given-names>G. C.</given-names></name> <name><surname>Soman</surname> <given-names>J.</given-names></name> <name><surname>Singleton</surname> <given-names>E. W.</given-names></name> <name><surname>Dewilde</surname> <given-names>S.</given-names></name> <name><surname>Moens</surname> <given-names>L.</given-names></name> <etal/></person-group>. (<year>2012</year>). <article-title>Determination of ligand pathways in globins: apolar tunnels versus polar gates</article-title>. <source>J. Biol. Chem.</source> <volume>287</volume>, <fpage>33163</fpage>&#x02013;<lpage>33178</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M112.392258</pub-id><pub-id pub-id-type="pmid">22859299</pub-id></citation>
</ref>
<ref id="B58">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Savino</surname> <given-names>C.</given-names></name> <name><surname>Miele</surname> <given-names>A. E.</given-names></name> <name><surname>Draghi</surname> <given-names>F.</given-names></name> <name><surname>Johnson</surname> <given-names>K. A.</given-names></name> <name><surname>Sciara</surname> <given-names>G.</given-names></name> <name><surname>Brunori</surname> <given-names>M.</given-names></name> <etal/></person-group>. (<year>2009</year>). <article-title>Pattern of cavities in globins: the case of human hemoglobin</article-title>. <source>Biopolymers</source> <volume>91</volume>, <fpage>1097</fpage>&#x02013;<lpage>1107</lpage>. <pub-id pub-id-type="doi">10.1002/bip.21201</pub-id><pub-id pub-id-type="pmid">19365817</pub-id></citation>
</ref>
<ref id="B59">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sengupta</surname> <given-names>D.</given-names></name></person-group> (<year>2012</year>). <article-title>Cholesterol modulates the structure, binding modes, and energetics of caveolin-membrane interactions</article-title>. <source>J. Phys. Chem. B</source> <volume>116</volume>, <fpage>14556</fpage>&#x02013;<lpage>14564</lpage>. <pub-id pub-id-type="doi">10.1021/jp3077886</pub-id><pub-id pub-id-type="pmid">23199331</pub-id></citation>
</ref>
<ref id="B60">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shaklai</surname> <given-names>N.</given-names></name> <name><surname>Yquerabide</surname> <given-names>J.</given-names></name> <name><surname>Ranney</surname> <given-names>H. M.</given-names></name></person-group> (<year>1977</year>). <article-title>Classification and localization of hemoglobin binding sites on the red blood cell membrane</article-title>. <source>Biochemistry</source> <volume>13</volume>, <fpage>5593</fpage>&#x02013;<lpage>5597</lpage>. <pub-id pub-id-type="doi">10.1021/bi00644a032</pub-id><pub-id pub-id-type="pmid">21687</pub-id></citation>
</ref>
<ref id="B61">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shapiro</surname> <given-names>R.</given-names></name> <name><surname>McManus</surname> <given-names>M. J.</given-names></name> <name><surname>Zalut</surname> <given-names>C.</given-names></name> <name><surname>Bunn</surname> <given-names>H. F.</given-names></name></person-group> (<year>1980</year>). <article-title>Sites of nonenzymatic glycosylation of human hemoglobin A</article-title>. <source>J. Biol. Chem.</source> <volume>255</volume>, <fpage>3120</fpage>&#x02013;<lpage>3127</lpage>. <pub-id pub-id-type="pmid">7358733</pub-id></citation>
</ref>
<ref id="B62">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Silvius</surname> <given-names>J. R.</given-names></name></person-group> (<year>2003</year>). <article-title>Role of cholesterol in lipid raft formation: lessons from lipid model systems</article-title>. <source>Biochim. Biophys. Acta</source> <volume>1610</volume>, <fpage>174</fpage>&#x02013;<lpage>183</lpage>. <pub-id pub-id-type="doi">10.1016/S0005-2736(03)00016-6</pub-id><pub-id pub-id-type="pmid">12648772</pub-id></citation>
</ref>
<ref id="B63">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Simons</surname> <given-names>K.</given-names></name> <name><surname>Toomre</surname> <given-names>D.</given-names></name></person-group> (<year>2000</year>). <article-title>Lipid rafts and signal transduction</article-title>. <source>Nat. Rev. Mol. Cell Biol.</source> <volume>1</volume>, <fpage>31</fpage>&#x02013;<lpage>39</lpage>. <pub-id pub-id-type="doi">10.1038/35036052</pub-id><pub-id pub-id-type="pmid">11413487</pub-id></citation>
</ref>
<ref id="B64">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Teeter</surname> <given-names>M. M.</given-names></name></person-group> (<year>2004</year>). <article-title>Myoglobin cavities provide interior ligand pathway</article-title>. <source>Protein Sci.</source> <volume>13</volume>, <fpage>313</fpage>&#x02013;<lpage>318</lpage>. <pub-id pub-id-type="doi">10.1110/ps.03334304</pub-id><pub-id pub-id-type="pmid">14739317</pub-id></citation>
</ref>
<ref id="B65">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tomasevic</surname> <given-names>N.</given-names></name> <name><surname>Nikolic</surname> <given-names>M.</given-names></name> <name><surname>Klappe</surname> <given-names>K.</given-names></name> <name><surname>Hoekstra</surname> <given-names>D.</given-names></name> <name><surname>Niketic</surname> <given-names>V.</given-names></name></person-group> (<year>2003</year>). <article-title>Insulin-induced lipid binding to hemoglobin</article-title>. <source>J. Serbe. Chem. Soc.</source> <volume>68</volume>, <fpage>25</fpage>&#x02013;<lpage>33</lpage>.</citation>
</ref>
<ref id="B66">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tomita</surname> <given-names>A.</given-names></name> <name><surname>Sato</surname> <given-names>T.</given-names></name> <name><surname>Ichiyanagi</surname> <given-names>K.</given-names></name> <name><surname>Nozawa</surname> <given-names>S.</given-names></name> <name><surname>Ichikawa</surname> <given-names>H.</given-names></name> <name><surname>Chollet</surname> <given-names>M.</given-names></name> <etal/></person-group>. (<year>2009</year>). <article-title>Visualizing breathing motion of internal cavities in concert with ligand migration in myoglobin</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A.</source> <volume>106</volume>, <fpage>2612</fpage>&#x02013;<lpage>2616</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0807774106</pub-id><pub-id pub-id-type="pmid">19204297</pub-id></citation>
</ref>
<ref id="B67">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>van den Akker</surname> <given-names>E.</given-names></name> <name><surname>Satchwell</surname> <given-names>T. J.</given-names></name> <name><surname>Williamson</surname> <given-names>R. C.</given-names></name> <name><surname>Toye</surname> <given-names>A. M.</given-names></name></person-group> (<year>2010</year>). <article-title>Band 3 multiprotein complexes in the red cell membrane; of mice and men</article-title>. <source>Blood Cells Mol. Dis.</source> <volume>45</volume>, <fpage>1</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1016/j.bcmd.2010.02.019</pub-id><pub-id pub-id-type="pmid">20346715</pub-id></citation>
</ref>
<ref id="B68">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Watanabe</surname> <given-names>M.</given-names></name> <name><surname>Miyazono</surname> <given-names>K.</given-names></name> <name><surname>Tanokura</surname> <given-names>M.</given-names></name> <name><surname>Sawasaki</surname> <given-names>T.</given-names></name> <name><surname>Endo</surname> <given-names>Y.</given-names></name> <name><surname>Kobayashi</surname> <given-names>I.</given-names></name></person-group> (<year>2010</year>). <article-title>Cell-free protein synthesis for structure determination by X-ray crystallography</article-title>. <source>Methods Mol. Biol.</source> <volume>607</volume>, <fpage>140</fpage>&#x02013;<lpage>160</lpage>. <pub-id pub-id-type="doi">10.1007/978-1-60327-331-2_13</pub-id><pub-id pub-id-type="pmid">20204855</pub-id></citation>
</ref>
<ref id="B69">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Weber</surname> <given-names>R. E.</given-names></name> <name><surname>Vinogradov</surname> <given-names>S. N.</given-names></name></person-group> (<year>2001</year>). <article-title>Nonvertebrate hemoglobins: functions and molecular adaptations</article-title>. <source>Physiol. Rev.</source> <volume>81</volume>, <fpage>569</fpage>&#x02013;<lpage>628</lpage>. <pub-id pub-id-type="pmid">11274340</pub-id></citation>
</ref>
<ref id="B70">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Weed</surname> <given-names>R. I.</given-names></name> <name><surname>Reed</surname> <given-names>C. F.</given-names></name> <name><surname>Berg</surname> <given-names>G.</given-names></name></person-group> (<year>1963</year>). <article-title>Is hemoglobin an essential structural component of human erythrocyte membranes?</article-title> <source>J. Clin. Invest.</source> <volume>42</volume>, <fpage>581</fpage>&#x02013;<lpage>588</lpage>. <pub-id pub-id-type="doi">10.1172/JCI104747</pub-id><pub-id pub-id-type="pmid">13999462</pub-id></citation>
</ref>
</ref-list>
</back>
</article>
